13.12.2012 Views

IP®EVIEW - Skadden

IP®EVIEW - Skadden

IP®EVIEW - Skadden

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Skadden</strong>, Arps, Slate, Meagher & Flom LLP<br />

and its affiliates provide this newsletter for<br />

educational and informational purposes only<br />

and it is not intended and should not be construed<br />

as legal advice. This newsletter is considered<br />

advertising under applicable state laws.<br />

IP® EVIEW<br />

Welcome to the <strong>Skadden</strong> IP Review<br />

Winter 2009<br />

Our latest edition includes two cover stories: a look at a recent Sixth Circuit ruling likely to affect IP license transfers in statutory<br />

mergers; and a follow-up report on how the U.S. Supreme Court’s potential adoption of the Federal Circuit’s “machine-or-transformation”<br />

test in its 2008 Bilski decision may impact the validity of patents and the claims of current applicants. We also cover topics<br />

such as the use of social media to promote FDA-regulated products and recent developments in FTC safe harbor enforcement, and<br />

discuss patents, trademarks, privacy and other issues.<br />

We welcome your comments and suggestions. A list of <strong>Skadden</strong>’s Intellectual Property and Technology contacts appears on page 18.<br />

Mergers and the Transfer of IP Licenses<br />

A recent ruling by the U.S. Court of Appeals for the Sixth Circuit<br />

prohibiting the transfer of an intellectual property license agreement<br />

in the context of what was, in effect, purely an internal corporate<br />

restructuring could have broad implications for many corporate transactions.<br />

In Cincom Systems Inc. v. Novelis Corp., 1 the court found<br />

that the defendant had violated the nontransferability provision of a<br />

license agreement because an entity other than the original licensee<br />

ended up holding the license (as a result of a statutory merger in<br />

which the original licensee was the nonsurviving entity). Although<br />

only binding in the Sixth Circuit, given the court’s broad ruling and the<br />

dearth of authority on the issue of transferring intellectual property<br />

licenses in statutory mergers, the case could have a broad impact.<br />

Background<br />

In 1989, Cincom Systems Inc. licensed Alcan Rolled Products Division<br />

the right to use certain Cincom software on a particular computer<br />

located in Oswego, N.Y. The license, which was governed<br />

by Ohio law, specified that it was not transferable by Alcan without<br />

Cincom’s prior written approval. 2 In 2003, Alcan’s parent corporation<br />

conducted a corporate reorganization pursuant to which Alcan<br />

was merged into a sister entity incorporated in Texas and Alcan<br />

( continued on page 2 )<br />

The Reign of Bilski: One Year After the<br />

Machine-or-Transformation Test<br />

On November 9, 2009, the U.S. Supreme Court heard oral<br />

argument on the proper test for patent-eligible subject matter<br />

under 35 U.S.C. § 101 and will subsequently determine, barring<br />

unforeseen circumstances, whether the Federal Circuit’s<br />

en banc decision in In re Bilski, 545 F.3d 943 (Fed. Cir. 2008),<br />

cert. granted, 129 S. Ct. 2735 (2009), applied the correct legal<br />

standard. Notwithstanding the pending review, a large number<br />

of decisions addressing patent eligibility have been rendered<br />

in the year since Bilski was decided. As highlighted below, the<br />

application of Bilski to issued patents and pending applications<br />

portends that Supreme Court adoption of the Federal Circuit’s<br />

“machine-or-transformation” test could significantly impact<br />

the scope of patent-eligible subject matter and the validity of<br />

patents that were issued prior to Bilski. Should the Supreme<br />

Court approve the Federal Circuit’s test, patent applicants will<br />

need to modify their pending claims accordingly, and patent<br />

owners will need to review their existing patent portfolios for<br />

compliance with the “machine-or-transformation” test (with the<br />

concomitant filing of reissue applications in order to modify the<br />

scope of claims that fail to pass the test).<br />

( continued on page 11 )<br />

Mergers and the Transfer of IP Licenses_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ p a g e 1<br />

The Reign of Bilski: One Year After the Machine-or-Transformation Test _ _ _ _ _ page 1<br />

FDA Conducts Public Hearing on the Use of the Internet and<br />

Social Media in the Promotion of FDA-Regulated Products _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ page 2<br />

Recent FTC Enforcement of Safe Harbor Has<br />

Broad Implications for Privacy Policies _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ page 3<br />

Federal Circuit Allows Hidden Unwitting Assignment by Employee<br />

Inventor to Defeat Standing to Sue for Patent Infringement _____________ page 5<br />

First Sale Doctrine Under Attack _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ page 6<br />

Federal Circuit Issues Two Key Decisions<br />

Clarifying Rights of Patent Licensees _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ page 8<br />

ISPs Immunity From Contributory Infringement Not Absolute _ _ _ _ _ _ _ _ _ _ _ _ page 9<br />

SEC Imposes $100,000 Fine for Firm’s Failure<br />

to Safeguard Customer Information ____________________________page 10<br />

<strong>Skadden</strong> Contacts _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _page 18


( continued from page 1 )<br />

Mergers and the Transfer of IP Licenses<br />

ceased to exist. After further corporate restructuring and multiple<br />

name changes, 3 Novelis Corp. emerged as the holder of the Cincom<br />

license. Nonetheless, the Cincom software continued to be used by<br />

the same business unit that was using it since 1989 and on the same<br />

designated computer in Oswego, N.Y. Novelis did not seek or obtain<br />

Cincom’s written consent to any portion of the reorganization. 4<br />

Cincom filed suit, alleging that the transfer of the license to Novelis<br />

violated that agreement’s anti-assignment clause, and that Novelis<br />

was infringing Cincom’s copyright by using the software.<br />

The Sixth Circuit’s Opinion<br />

The Sixth Circuit began by citing the fundamental principle that, under<br />

federal law, intellectual property licenses cannot be assigned without<br />

express consent. According to the court, without such a prohibition,<br />

a licensor would effectively lose control of its intellectual property<br />

asset. Therefore, while state law can govern the interpretation of an<br />

intellectual property license, it cannot be used to reverse the federal<br />

prohibition against the unauthorized transfer of intellectual property<br />

licenses. According to the court, since Ohio merger law operated to<br />

transfer the license from Alcan to Novelis, Novelis had breached the<br />

nontransferability provision of the license and was using Cincom’s<br />

copyrighted software without permission.<br />

The court cited its 1979 decision in PPG Industries, Inc. v. Guardian<br />

Industries Corp. 5 to support its holding. In that case, PPG had<br />

granted Permaglass a nontransferable patent license. Permaglass<br />

then merged into Guardian, a competitor of PPG. Under Delaware<br />

and Ohio law, which governed that merger, Permaglass’ licenses<br />

automatically transferred to Guardian. The Sixth Circuit held, however,<br />

that state law could not override the presumption that intellectual<br />

property licenses were nonassignable without express consent, and<br />

therefore Guardian was in breach of the license. 6<br />

Novelis attempted to distinguish PPG on the grounds that the surviving<br />

entity in that case was a competitor of the licensor. The court<br />

acknowledged that the primary purpose of the federal law prohibiting<br />

unauthorized transfers was to prevent a license from falling into the<br />

hands of a competitor. However, the court stressed that this federal<br />

law applies in all circumstances, not just those in which there is a<br />

transfer to a competitor.<br />

Novelis next argued that the court should reconsider its holding in PPG<br />

given that the Ohio merger statute had been modified since 1979 and<br />

now appeared to clarify that a merger did not effectuate a transfer of<br />

all agreements. Specifically, when PPG was decided, Ohio’s merger<br />

law stated that all assets of the nonsurviving party in a merger were<br />

“deemed to be [t]ransferred to and vested in” the survivor. 7 Ohio subsequently<br />

adopted a new merger statute which states that all assets<br />

of the nonsurviving party to a merger are “vested in” the survivor. 8<br />

Novelis argued that the deletion of the word “transferred” from the<br />

statute indicates that a merger under Ohio law is no longer a transfer.<br />

Therefore, when Novelis became the licensee under the Cincom<br />

license, it was not because a “transfer” had taken place. 9<br />

The court rejected this argument, noting that the vesting of a license<br />

in a new entity could only occur if it was transferred from the old<br />

entity. More importantly, the court stated broadly that “in the context<br />

of a patent or copyright license, a transfer occurs any time an entity<br />

other than the one to which the license was expressly granted gains<br />

possession of the license” (emphasis in original). 10 Moreover, the<br />

IP® EVIEW<br />

2<br />

court indicated that even if the license is silent as to transferability, the<br />

federal rule would prohibit transfer without consent.<br />

Practical Implications<br />

Although Cincom is binding only on courts in the Sixth Circuit, given<br />

the dearth of case law in this area, licensors seeking to challenge a<br />

transfer will likely urge courts in other circuits to follow the logic of<br />

the Cincom court. This case could therefore be the basis of a new<br />

de facto standard in which licensor consent is required even in the<br />

context of statutory mergers. This could increase transaction costs<br />

(if the licensor seeks compensation for its consent) and could delay a<br />

signing or closing (while consents are obtained).<br />

Ultimately, the greatest challenge for licensors and licensees may<br />

be determining the full reach of the Cincom decision. Read literally,<br />

the court’s somewhat ambiguous holding — that a transfer of an<br />

IP license has occurred any time a new entity “gains possession”<br />

of the original licensee — easily could encompass sales of stock<br />

and other corporate transactions that generally are not thought of<br />

as requiring consent from IP licensors. Although it seems unlikely<br />

that the court intended such a result, it is difficult to discern a clear<br />

boundary from its reasoning or holding. Until such time (if any) that<br />

Cincom is further clarified, parties should carefully analyze proposed<br />

corporate transactions in light of their existing IP licenses and the<br />

holding in Cincom.<br />

Finally, Cincom turned on the fact that the license included a broad<br />

prohibition against transfer. When negotiating license agreements<br />

going forward, licensees should be sure to seek the right to transfer<br />

the license without consent in the context of a merger or other<br />

change of control events. �<br />

1 2009 U.S. App. LEXIS 21172 (6 th Cir.).<br />

2 Id. at *2.<br />

3 The Sixth Circuit is somewhat unclear about the specifics of these other steps,<br />

stating that the Texas entity merged into itself and three of its subsidiaries. Id. at *4.<br />

However, there were stipulated facts filed with the district court that described the<br />

corporate restructuring efforts. In effect, the licensee was merged out of existence.<br />

4 Id. at *3.<br />

5 597 F.2d 1090 (6 th Cir. 1979).<br />

6 The license agreement at issue in PPG was terminable by the licensor if the licensee<br />

became controlled by a competitor of the licensor.<br />

7 Ohio Rev. Code Ann. § 1701.81(A)(4)(1955).<br />

8 Ohio Rev. Code Ann. § 1701.82(A)(3)(2009).<br />

9 Cincom at *15.<br />

10 Cincom at *16 – *17.<br />

FDA Conducts Public Hearing on the Use of<br />

the Internet and Social Media in the Promotion<br />

of FDA-Regulated Products<br />

On November 12 and 13, 2009, the United States Food and Drug<br />

Administration (FDA) held a public hearing and request for comments<br />

to discuss issues related to the promotion of FDA-regulated<br />

products (e.g., prescription drugs, prescription biologics and medical<br />

devices) using the Internet and social media tools. 1 Comments will<br />

be accepted until February 28, 2010.<br />

( continued on page 3 )


( continued from page 2 )<br />

Background<br />

In the official notice announcing the hearing, the FDA recognized that<br />

the Internet has become a widely used medium for FDA-regulated<br />

companies (e.g., manufacturers, packers and distributors of regulated<br />

products) to disseminate information about their products. The FDA<br />

also acknowledged that the second generation of Web development<br />

and Web design (Web 2.0) has led to the emergence of a variety of<br />

social networking tools (e.g., blogs, podcasts, social network sites,<br />

video sharing, widgets and wikis) that have raised questions and concerns<br />

over how to apply existing FDA regulations to these newer media.<br />

As a result, the FDA has been evaluating the extent to which existing<br />

laws, regulations and policies concerning advertising and promotional<br />

labeling of regulated products should be applied on the Internet.<br />

To date, however, the FDA has not issued specific regulations or<br />

guidance on Internet promotions, despite the industry’s continued<br />

request for such guidance. Instead, the FDA has continued to<br />

apply its “print-based” media rules to online promotion, essentially<br />

ignoring the special characteristics of Web 2.0 and other<br />

emerging technologies.<br />

Past FDA Enforcement Activity Relating to Online Promotion<br />

Sponsored Links<br />

In April 2009, the FDA issued Untitled Letters 2 to 14 pharmaceutical<br />

companies for violations relating to sponsored links on search<br />

engines. 3 Sponsored links are links or ads that are purchased to<br />

appear when a certain search term is entered. In this case, companies<br />

paid for their links to appear when searches were run for either<br />

the brand names of drug products or disease conditions. In each<br />

Untitled Letter, the FDA generally cited violations of the Food, Drug<br />

and Cosmetic Act (FDCA).<br />

Specifically, the FDA asserted that the sponsored links misbrand<br />

the drugs because they include representations and/or suggestions<br />

about their efficacy without communicating any risk information.<br />

Furthermore, the FDA stated that providing a link to the product’s<br />

Web site, where consumers could get more information about drug<br />

risks, did not mitigate the misleading omission of risk information.<br />

The Untitled Letters also claimed that the sponsored links failed adequately<br />

to communicate the drugs’ indication (i.e., what the drugs are<br />

used for) or, in some instances, broadened the indication by failing<br />

to disclose limitations to the indication, such as the appropriate<br />

patient population or disease stage. Finally, the FDA asserted that<br />

the sponsored links do not provide the drugs’ full established names<br />

in accordance with FDA regulations. In other words, the sponsored<br />

links refer only to the drugs’ proprietary names without also providing<br />

their established names (also known as “generic names”).<br />

YouTube Videos and Banner Ads<br />

Although the majority of the FDA’s online enforcement activities<br />

have focused on companies’ practices on official product Web<br />

sites, the FDA has also issued Warning Letters addressing the use<br />

of videos posted on third-party Web sites, and Untitled Letters<br />

addressing the use of “online banners.”<br />

For example, in August 2008, the FDA sent an Untitled Letter to<br />

Novartis Pharmaceuticals, objecting to the company’s use of online<br />

banners promoting Diovan. The FDA claimed that the banner ads<br />

presented efficacy claims but failed to communicate required risk<br />

information, thereby misbranding the drug.<br />

IP® EVIEW<br />

3<br />

Issues for Discussion<br />

According to the notice, the FDA is interested in comments on any<br />

aspect of Internet promotion in general. However, the FDA identified<br />

the following five categories for discussion at the November public<br />

hearing, based in large part on the specific types of issues frequently<br />

raised by interested parties.<br />

• For what online communications are manufacturers, packers or<br />

distributors of regulated products accountable?<br />

• How can manufacturers, packers or distributors fulfill regulatory<br />

requirements in their Internet and social media promotion?<br />

• What parameters should apply to the posting of corrective information<br />

on Web sites controlled by third parties?<br />

• When is the use of links appropriate?<br />

• Questions specific to Internet-adverse event reporting, including:<br />

How are entities with reporting responsibilities using the Internet<br />

and social media tools with regard to monitoring adverse event<br />

information about their products?<br />

With the emergence of new Web 2.0 technologies, the regulation<br />

of Internet and social media promotions will continue to present<br />

considerable challenges for the FDA and the industry as a whole.<br />

Therefore, it is important that all interested parties review the public<br />

notice and consider sending comments in order to assist the FDA in<br />

developing practical rules and regulations to accommodate a wide<br />

range of online promotional tools. �<br />

1 The Notice of Public Hearing: http://edocket.access.gpo.gov/2009/pdf/E9-22618.pdf.<br />

2 Untitled Letters “cite[] violations that do not meet the threshold or regulatory<br />

significance for a Warning Letter.” See FDA, Regulatory Procedures Manual at 4-2-1<br />

(Mar. 2009). Such violations “may lead to enforcement action if not promptly and<br />

adequately corrected.” Id at 4-1-1.<br />

3 The 14 Untitled Letters can be viewed on the FDA’s Web site: http://www.fda.gov/<br />

Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/<br />

WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/<br />

ucm055773.htm.<br />

Recent FTC Enforcement of Safe Harbor Has<br />

Broad Implications for Privacy Policies<br />

On October 6, 2009, the Federal Trade Commission (FTC) announced<br />

that it had settled charges brought against six different companies for<br />

misrepresenting that they were in compliance with the U.S.-European<br />

Union (EU) Safe Harbor framework (Safe Harbor). 1 These settlements<br />

mark the second time within the last two months that the FTC has<br />

settled a claim relating to the Safe Harbor, and may signal new scrutiny<br />

by the FTC into Safe Harbor compliance — an area that the FTC<br />

has not addressed since the framework was put in place 10 years ago.<br />

The FTC’s actions also serve as an important reminder that companies<br />

must be in compliance with all aspects of their stated privacy policies,<br />

whether or not they certify to the Safe Harbor.<br />

Safe Harbor Overview<br />

The EU Directive on Data Protection, 2 which went into effect in<br />

1998, generally prohibits the transfer of personal data to non-EU<br />

nations that do not meet the EU standard of “adequate” privacy protection.<br />

This presented a potential impediment for data transfers to<br />

( continued on page 4 )


( continued from page 3 )<br />

the U.S. given the U.S. reliance on industry self-regulation to protect<br />

many types of personal data. While companies may use so-called<br />

“model contracts” (i.e., written agreements that specify the means<br />

by which data will be protected), the U.S. Department of Commerce<br />

sought to create a streamlined method by which U.S. companies could<br />

meet the “adequacy” requirement of the directive.<br />

The Department of Commerce and the European Commission therefore<br />

negotiated a Safe Harbor framework which became effective<br />

in 2000. 3 By certifying to the Safe Harbor, a company establishes<br />

that it provides “adequate” data privacy protection as required under<br />

the EU Directive, and may therefore lawfully transfer personal data<br />

from the EU. In order to participate, companies must self-certify to<br />

the Department of Commerce that they comply with seven specified<br />

privacy principles — notice, choice, transfer to third parties,<br />

security, access, data integrity and enforcement. Most importantly<br />

for purposes of the recent FTC actions, participating companies<br />

must state in their published privacy policies that they adhere to the<br />

Safe Harbor, and must recertify each year if they choose to continue<br />

relying on this framework for EU-U.S. data transfers. Companies<br />

that fail to recertify are listed as “not current” on the Department of<br />

Commerce Web site.<br />

The FTC Enforcement Actions<br />

At various points between 2001 and 2007, the six settling companies<br />

had self-certified under the Safe Harbor. As required, each company<br />

also included a statement in its Web site privacy policy that it was<br />

participating in the Safe Harbor program and was adhering to the<br />

Safe Harbor Privacy Principles. 4 Several of the companies recertified<br />

at least once before ceasing to do so, while the remaining<br />

companies never recertified. In all instances, the Department of<br />

Commerce moved each company to its “not current” list, indicating<br />

that the companies had failed to recertify.<br />

Despite the fact that the companies had not recertified, each of them<br />

continued to include a statement in their privacy policy that they<br />

were Safe Harbor compliant. This erroneous statement remained<br />

on each company’s Web site for periods ranging from approximately<br />

six months to five years before the FTC brought its actions in the<br />

summer of 2009. In each case, the FTC alleged that because of the<br />

misleading statement regarding Safe Harbor compliance, each company<br />

had committed unfair or deceptive acts or practices in violation of<br />

Section 5(a) of the Federal Trade Commission Act.<br />

On October 6, 2009, the FTC announced its settlement with all six<br />

companies and issued proposed consent orders. 5 Pursuant to the<br />

consent orders, each company agrees not to “misrepresent in any<br />

manner, expressly or by implication, the extent to which [it] is a<br />

member of, adheres to, complies with, is certified by, is endorsed by,<br />

or otherwise participates in any privacy, security, or other compliance<br />

program sponsored by the government or any other third party.” 6<br />

For a period of five years, the companies must also maintain, and<br />

make available to the FTC, copies of all documentation related to<br />

compliance with the order, including advertisements, promotional<br />

materials and other statements containing representations covered<br />

by the orders.<br />

Implications of the FTC’s Actions<br />

Notably, the six settlements mark the second time within the last<br />

two months that the FTC has brought charges against a company for<br />

misrepresenting its Safe Harbor status. In August 2009, the FTC<br />

IP® EVIEW<br />

4<br />

obtained a temporary restraining order against a company for a number<br />

of allegedly deceptive acts or practices, including falsely representing<br />

that it self-certified to Safe Harbor when in fact the company had<br />

never participated in the program. 7 These recent actions suggest<br />

that the FTC may be responding to long-standing suggestions by the<br />

EU that the FTC needs to be proactive in monitoring whether organizations’<br />

privacy policies conform to the Safe Harbor. 8 Regardless of<br />

the FTC’s motivation, its recent focus in this area serves as an important<br />

reminder to companies that they must continue to re-certify<br />

their Safe Harbor compliance, or modify their privacy policies if they<br />

have chosen not to recertify or neglected to do so.<br />

These recent Safe Harbor cases are also consistent with recent<br />

efforts by the FTC to ensure that privacy policies are clear and match<br />

a company’s actual activities. Earlier this year, the FTC settled<br />

charges against an online retailer whose systems were hacked,<br />

exposing its customers’ data. The FTC claimed that the company’s<br />

privacy policy inaccurately described the strength of its information<br />

security policies. 9 Similarly, in its revised principles governing the<br />

use of personal data for online behavioral advertising, the FTC<br />

expressed its discontent with the “opaque privacy policies that only<br />

a lawyer can understand.” 10<br />

Practice Points<br />

• Companies that have self-certified to the Safe Harbor must<br />

keep in mind that they are required to self-certify each year if<br />

they want to remain under the protection of this framework<br />

to transfer personally identifiable data from the EU to the U.S.<br />

Companies should establish internal “reminders” so that they<br />

can begin the recertification process sufficiently in advance of<br />

when it is due.<br />

• Companies that have decided not to self-certify, or realize they<br />

have neglected to do so, must immediately modify their privacy<br />

polices to reflect that fact.<br />

• Even if a company is not certified under the Safe Harbor, it is<br />

critical for it to self-certify to ensure that its privacy policy accurately<br />

captures the company’s activities. Any inaccuracy can lead<br />

to a claim of unfair and deceptive misleading practices by the FTC.<br />

While an inaccurate privacy policy might seem like a minor issue,<br />

note that the implications can be significant if the FTC brings<br />

actions. In the six recently settled cases, the companies are<br />

prohibited from misrepresenting, expressly or by implication, their<br />

adherence to any compliance program, whether sponsored by the<br />

government or any other third party. �<br />

1 See Press Release, Fed. Trade Comm’n, FTC Settles with Six Companies Claiming to<br />

Comply with International Privacy Framework (Oct. 6, 2009), available at http://www.<br />

ftc.gov/opa/2009/10/safeharbor.shtm.<br />

2 Council Directive 95/46/EC, 1995 O.J. (L 281) 31 (EC).<br />

3 Participation is available only to those companies coming under the jurisdiction of the<br />

FTC or the U.S. Department of Transportation.<br />

4 See, e.g., Complaint at 3, In the matter of Progressive Gaitways LLC, No. 092-3141<br />

(Fed. Trade Comm’n 2009).<br />

5 The proposed consent orders are subject to public comment through November 5,<br />

2009, at which point the FTC will determine whether to finalize the orders.<br />

6 See, e.g., Agreement Containing Consent Order, In the Matter of World Innovators,<br />

Inc., No. 092-3137 (Fed. Trade Comm’n Oct. 6, 2009).<br />

7 Press Release, Fed. Trade Comm’n, Court Halts U.S. Internet Seller Deceptively<br />

Posing as U.K. Home Electronics Site (Aug. 6, 2009), available at http://www.ftc.gov/<br />

opa/2009/08/bestpriced.shtm.<br />

( continued on page 5 )


( continued from page 4 )<br />

8 See, e.g., Commission Staff Working Document on the Implementation of<br />

Commission Decision 520/2000/EC on the Adequate Protection of Personal Data<br />

Provided by the Safe Harbor Privacy Principles and Related Frequently Asked<br />

Questions Issued by the US Department of Commerce (Oct. 2004), available at<br />

http://ec.europa.eu/justice _home/fsj/privacy/docs/adequacy/sec-2004-1323 _en.pdf.<br />

9 See Press Release, Fed. Trade Comm’n, Identity Theft, Consumer Electronics<br />

Company Agrees to Settle Data Security Charges; Breach Compromised Data of<br />

Hundreds of Consumers (Feb. 5, 2009), available at http://www.ftc.gov/opa/2009/02/<br />

compgeeks.shtm.<br />

10 Fed. Trade Comm’n, Self-Regulatory Principles for Online Behavioral Advertising:<br />

Behavioral Advertising Tracking, Targeting, & Technology (2009), available at http://<br />

www.ftc.gov/os/2009/02/P085400behavadreport.pdf.<br />

Federal Circuit Allows Hidden Unwitting<br />

Assignment by Employee Inventor to Defeat<br />

Standing to Sue for Patent Infringement<br />

A recent decision by the U.S. Court of Appeals for the Federal Circuit<br />

in Board of Trustees of The Leland Stanford Junior University, et al., v.<br />

Roche Molecular Systems, Inc. et al. underscores the need to draft<br />

employee intellectual property assignment agreements with care<br />

and to consider carefully how to structure arrangements that permit<br />

employees to work as consultants to partners or third parties.<br />

Background<br />

The patents-in-suit claim methods for quantifying Human<br />

Immunodeficiency Virus (HIV) in human blood samples, and correlating<br />

those measurements to the therapeutic effectiveness of<br />

antiretroviral drugs. Three Stanford researchers — Mark Holodniy,<br />

Thomas Merigan and David Katzenstein — are named inventors<br />

on all of the patents; a fourth inventor, Michael Kozal, appears on<br />

one of the patents. The technology related to the patents-in-suit<br />

was developed in the late 1980s and early 1990s by researchers at<br />

Stanford and Cetus, a company where polymerase chain reaction<br />

(PCR) techniques matured in the early 1980s.<br />

In 1988, Holodniy joined Merigan’s laboratory at Stanford and<br />

signed a “Copyright and Patent Agreement” (CPA) that obligated<br />

him to assign his inventions to the university. In the CPA, Holodniy<br />

acknowledged that Stanford enters into “Contracts or Grants” with<br />

third parties, such as the government, and that he may “conceive<br />

or first actually reduce to practice” various inventions. Paragraph<br />

2 of the CPA then recites: “I agree to assign or confirm in writing<br />

to Stanford and/or Sponsors that right, title and interest in … such<br />

inventions as required by Contracts or Grants.”<br />

In February 1989, Holodniy began regular visits to Cetus over<br />

several months to learn PCR and to develop a PCR-based assay for<br />

HIV. Holodniy signed a “Visitor’s Confidentiality Agreement” (VCA)<br />

with Cetus. The VCA stated that Holodniy “will assign and do[es]<br />

hereby assign to CETUS, my right, title, and interest in each of the<br />

ideas, inventions and improvements” that Holodniy may devise “as<br />

a consequence of” his work at Cetus. Stanford was unaware of<br />

the VCA entered into by Holodniy, and no recordation of it was ever<br />

made in relation to any patent. Eventually, Holodniy’s research with<br />

Cetus produced an assay that used PCR to measure quantitatively<br />

the amount of plasma HIV RNA in samples from infected humans.<br />

Results obtained by the Stanford team using the new assay formed<br />

the basis for the patents-in-suit. Stanford and Cetus were also<br />

parties to various material transfer and other agreements related to<br />

this work.<br />

IP® EVIEW<br />

5<br />

In December 1991, Roche purchased Cetus’s PCR business, including<br />

its agreements with Stanford and its researchers. After this transaction,<br />

Roche began manufacturing HIV detection kits employing RNA<br />

assays. In May 1992, Stanford filed the patent application to which<br />

the patents-in-suit claim priority. The ’730 patent issued on October<br />

19, 1999; the ’705 patent issued on January 7, 2003; and the ’041<br />

patent issued on October 31, 2006, after this lawsuit began. Stanford<br />

is the named assignee of all three patents.<br />

Stanford received government funding for its HIV research through<br />

the National Institutes of Health (NIH). On June 24, 1992, Stanford<br />

filed an invention disclosure for the HIV RNA assay with the NIH. On<br />

November 29, 1994, Stanford confirmed to the government the grant<br />

of a “nonexclusive, nontransferable, irrevocable, paid-up license”<br />

under the parent application. On April 6, 1995, Stanford formally<br />

notified the government that it elected to retain title to the inventions<br />

under the Bayh-Dole Act, 35 U.S.C. §§ 200-212.<br />

Following failed discussions regarding licensing the patents, Stanford<br />

filed suit against Roche in the Northern District of California on<br />

October 14, 2005, alleging that Roche’s HIV detection kits infringe<br />

its patents. Roche answered and counterclaimed against Stanford,<br />

Merigan and Holodniy, asserting, inter alia, that Stanford lacked<br />

standing to maintain the cause of action against Roche, that Roche<br />

possesses ownership, license and/or shop rights to the patents<br />

through Roche’s acquisition of Cetus’s PCR assets, and that the<br />

asserted patent claims were invalid.<br />

The parties cross-moved for summary judgment on Roche’s rights<br />

in the patents, and the district court ruled that Roche’s pleading<br />

was a counterclaim subject to the applicable statute of limitations<br />

and not an affirmative defense, and ruled in Stanford’s favor on the<br />

ownership and standing issues finding that (1) Roche’s ownership<br />

claims were barred by California statutes of limitation, laches and the<br />

Bayh-Dole Act; (2) Roche’s license claims failed because Stanford<br />

never consented to Roche’s acquisition of Cetus’s patent licenses;<br />

and (3) Roche lacked shop rights to the patents.<br />

After briefing and a Markman hearing, the district court then<br />

construed several claim terms. Roche then moved for summary<br />

judgment that the asserted claims were invalid. The district court<br />

granted the motion, holding all asserted claims obvious.<br />

Stanford appealed the judgment of invalidity, and Roche crossappealed<br />

the judgment as to the parties’ respective rights in the<br />

patents.<br />

The Federal Circuit’s Decision<br />

On appeal, the Federal Circuit affirmed the district court’s dismissal<br />

of Roche’s ownership counterclaim, vacated the judgment that the<br />

asserted patent claims were invalid for obviousness, and remanded<br />

with instructions to dismiss Stanford’s claim because, despite its<br />

agreement with Holodniy and no actual notice of an assignment to<br />

Cetus, Stanford cannot establish ownership of Holodniy’s interest<br />

and therefore lacks standing to assert its claims of infringement<br />

against Roche.<br />

Present Versus Future Agreements to Assign<br />

A threshold issue in the case was which of the various agreements<br />

involving Holodniy (the CPA, the VCA or the recorded assignment<br />

to Stanford) was effective to transfer his interest in the invention.<br />

The Federal Circuit looked at the language in the CPA and VCA and<br />

( continued on page 6 )


( continued from page 5 )<br />

held that when he “agree[d] to assign” in the CPA, Holodniy merely<br />

promised to assign rights in the future to Stanford, while the VCA’s<br />

language of “do hereby assign” effected a present assignment of<br />

Holodniy’s future inventions to Cetus. Therefore, Cetus immediately<br />

gained equitable title to Holodniy’s inventions and once the invention<br />

was made and an application for patent was filed, Cetus’s equitable<br />

title converted to legal title. Although Holodniy executed an assignment<br />

of his rights in the parent application to Stanford, because Cetus’s legal<br />

title vested first, Holodniy no longer retained any rights, negating his<br />

subsequent assignment to Stanford during patent prosecution.<br />

Because it was undisputed that Holodniy took certain information<br />

and material from Cetus and used them to develop the PCR assay<br />

for HIV RNA. The Federal Circuit agreed with the district court<br />

that he developed the inventions “as a consequence” of his access<br />

to Cetus. Even if Holodniy conceived and reduced to practice after<br />

departing Cetus, his research was directly related to the collaboration<br />

with Cetus. Thus, the chain of title to Holodniy’s rights leads to Roche,<br />

leaving Stanford with defective title to the rights of all the inventors.<br />

Bona Fide Purchaser Under 35 U.S.C § 261<br />

Stanford asserted that it was a bona fide purchaser for value of<br />

Holodniy’s interest in the patents by virtue of the CPA and that Cetus’s<br />

failure to timely record the VCA gave Stanford superior title to that of<br />

Roche under 35 U.S.C. § 261. The Federal Circuit disagreed.<br />

In disagreeing with Stanford, the Federal Circuit first observed that<br />

the bona fide purchaser defense to patent infringement, while a<br />

matter of federal law, draws upon common law principles. On the<br />

basis of common law principles and dicta from one of its previous<br />

cases, 1 the court concluded that notice under Section 261 can<br />

include constructive or inquiry notice, in addition to actual notice, and<br />

that Stanford should be charged with notice of Holodniy’s assignment<br />

to Cetus on the basis that (1) the CPA established an employment<br />

relationship between Holodniy and Stanford, and Holodniy’s<br />

work at Cetus related directly to his research at the university; (2)<br />

Merigan, Holodniy’s supervisor at Stanford, directed Holodniy to<br />

work with Cetus and himself executed Materials Transfer Agreements<br />

with Cetus that allocated intellectual property rights; and<br />

(3) constructive notice applies under California law in particular to<br />

employees who are acting as agents of their employer. The Federal<br />

Circuit also found that Holodniy’s promise in signing the CPA to “not<br />

enter into any agreement creating copyright or patent obligations in<br />

conflict with this agreement” does not prevent imputation of notice<br />

to Stanford.<br />

Bayh-Dole Considerations<br />

Stanford contended that the Bayh-Dole Act allowed Stanford a “right<br />

of second refusal” to the patents after the government refrained<br />

from exercising its rights, that Holodniy’s rights were contingent<br />

upon his CPA obligations to assign them to Stanford, and that the act<br />

voided any assignment by Holodniy to Cetus upon Stanford electing<br />

title to the invention. The Federal Circuit disagreed, relying on its<br />

previous holding, that, 2 when the Bayh-Dole Act’s provisions are<br />

violated, the government can choose to take action and title to the<br />

patent may be voidable, but the Federal Circuit declined to expand<br />

that holding to find that title is automatically void. Instead, the<br />

Federal Circuit held that Holodniy’s assignment to Cetus provided<br />

the government with, at most, a discretionary option to his rights,<br />

but that absent exercise of that option, title remained with Holodniy<br />

or his assignee (Cetus).<br />

IP® EVIEW<br />

6<br />

The court went on to note that, at the time it elected title, Stanford<br />

was entitled to claim whatever rights were still available after the<br />

government declined to exercise its option, including the rights of coinventors<br />

Merigan, Katzenstein and Kozal. Holodniy, however, had<br />

transferred his rights to Cetus more than six years before Stanford<br />

formally notified the government of its election of title. The court<br />

specifically declined to express an opinion as to whether Holodniy’s<br />

execution of the VCA violated any provisions of the Bayh-Dole Act,<br />

or whether the act provides the government or Stanford some other<br />

legal recourse to recover Holodniy’s rights.<br />

Ownership and Standing<br />

While the court held Stanford is not able to establish clear title<br />

through all the inventors, it also upheld the district court’s dismissal<br />

of Roche’s ownership claims as time-barred under California’s applicable<br />

statute of limitations. Thus Roche was not awarded a judgment<br />

of ownership. Nonetheless, the court found that Stanford’s<br />

inability to establish that it possessed Holodniy’s interest in the<br />

patents-in-suit defeats its right to assert its cause of action against<br />

Roche, as it is well settled that “all co-owners normally must join<br />

as plaintiffs in an infringement suit. Thus, the Federal Circuit found<br />

that the district court lacked jurisdiction over Stanford’s infringement<br />

claim and should not have addressed the validity of the patents. �<br />

1 FilmTec Corp. v. Allied-Signal, Inc., 939 F.2d 1568, 1574 (Fed. Cir. 1991).<br />

2 Central Admixture Pharmacy Services, Inc. v. Advanced Cardiac Solutions, P.C. 482<br />

F.3d 1347, 1352-53 (Fed. Cir. 2007).<br />

First Sale Doctrine Under Attack<br />

A long-standing skirmish between brand owners and retailers over<br />

the right of unauthorized retailers to sell authorized goods recently<br />

has taken a pivotal turn. In a recent decision, Zino Davidoff SA v.<br />

CVS Corp, 1 the U.S. Court of Appeals for the Second Circuit held<br />

that the removal by a retailer of a Unique Production Code (UPC) on<br />

the plaintiff’s fragrance packaging violated the plaintiff’s trademark<br />

rights. As such, at least in the Second Circuit, a retailer that is not<br />

authorized to sell a branded product now may face the difficult<br />

dilemma of removing the UPC and risk engaging in trademark<br />

infringement or keep the UPC on the product packaging and facilitate<br />

the brand owner’s discovery (and termination) of the source of the<br />

diverted goods. In either event, the unauthorized resale of branded<br />

goods as we have come to know it may permanently be altered.<br />

Background<br />

For years, retailers have sold with relative impunity branded goods<br />

that were not intended by the brand owner to be sold through that<br />

retailer. We all have seen such sales, whether personal fragrances,<br />

designer apparel, luxury goods, fine chocolate or other high-end (and<br />

authentic) branded products being sold at a discount by a discount<br />

retail chain. Frequently such goods are sold directly to the discount<br />

retail chain by the brand owner’s exclusive distributors or by the<br />

unauthorized high-end retailer itself, seeking to sell excess inventory<br />

that the distributor or high-end retailer may not be able to sell<br />

through authorized channels.<br />

Brand owners have had a number of concerns regarding such resale,<br />

including that such unauthorized channels are not consistent with<br />

the image of the brand, do not provide service that consumers of<br />

( continued on page 7 )


( continued from page 6 )<br />

the brand would come to expect, undercut sales and potentially put<br />

pricing pressure on authorized retailers, and make it more difficult<br />

to identify and prevent sales of counterfeit goods. Nonetheless,<br />

brand owners by and large have been on the losing side of the legal<br />

battle challenging such conduct, as the products at issue fulfilled<br />

a fundamental principle of trademark law — that they are original<br />

goods emanating from the brand owner (i.e., the product is no different<br />

from that sold by authorized retailers). Put simply, courts held<br />

that consumers could not be confused about the origin of a good<br />

when the origin had not changed, just the sales outlet had. 2 Brand<br />

owners adopted and pressed alternative legal theories to stop<br />

such sales, such as tortious interference with contract (i.e., that<br />

the retailer tortiously interfered with the brand owners’ exclusive<br />

distribution relationships). But given the additional elements<br />

that a plaintiff must present to establish such a tort (i.e., retailer<br />

knowledge of the exclusive relationship and an intent to interfere<br />

with such relationship), and that the genuine goods frequently<br />

would travel through multiple parties such that the retailer would<br />

not have diverted the goods from the distributor that was subject<br />

to the contractual restriction with the brand owner, brand owners<br />

frequently failed here as well. Brand owners also resorted to<br />

self-help, by purchasing unauthorized product and attempting to<br />

trace its origins (and the cause of the diversion), but retail stores<br />

selling such unauthorized goods typically remove UPCs and similar<br />

identifying characteristics to avoid such detection. Challenges by<br />

brand owners that such UPC removal itself constituted trademark<br />

infringement by modifying the product such that it was no longer<br />

an original met with limited success. 3<br />

Such was the legal landscape when Zino Davidoff SA (Davidoff), the<br />

Switzerland-based manufacturer of luxury items, challenged CVS<br />

Corporation (CVS), the pharmacy chain, for its unauthorized sales<br />

of Davidoff’s Cool Water brand perfume. Davidoff distributes such<br />

fragrances to select high-end retailers in the United States. CVS was<br />

not an authorized retailer of the Cool Water fragrance, but was able<br />

to obtain Cool Water inventory through secondary distribution channels<br />

— i.e., the “gray market.” Cool Water fragrances were among<br />

CVS’s top-selling fragrances.<br />

On three different occasions over the years, Davidoff had discovered<br />

that, in addition to fragrances acquired via the gray market, CVS also<br />

was selling counterfeit Cool Water fragrances. After the third occasion,<br />

Davidoff sought and secured a temporary restraining order in<br />

the U.S. District Court for the Southern District of New York against<br />

CVS with respect to such counterfeit product. The court additionally<br />

authorized Davidoff to inspect all the undistributed Cool Water products<br />

in CVS’s inventory to investigate how pervasive the counterfeits<br />

were. During the course of the inspection, Davidoff discovered<br />

that the UPCs had been removed from the packaging of 16,600<br />

fragrances. Because Davidoff perceived the sale of these items to<br />

be a threat to its anti-counterfeiting measures, it sought a preliminary<br />

injunction preventing CVS from selling all Cool Water products with the<br />

UPC removed regardless of whether the product was genuine or not.<br />

The Court’s Decision<br />

The Southern District of New York granted a preliminary injunction<br />

and CVS appealed. The Second Circuit affirmed the preliminary<br />

injunction. The appellate court agreed with the district court that<br />

Davidoff likely would succeed in its trademark infringement claim,<br />

finding that CVS interfered with Davidoff’s right to control the<br />

quality of the product under the Lanham Act. The court ordered<br />

CVS to stop selling such items, genuine or not, with the UPC<br />

IP® EVIEW<br />

7<br />

removed. Davidoff introduced evidence that, as part of its quality<br />

control measures, the UPC on each fragrance package, which<br />

enables Davidoff to trace each product through the production<br />

and distribution line to final sale, helps identify and resolve quality<br />

issues as they arise. The Second Circuit stated that “because the<br />

UPC acts as a quality control mechanism which enables Davidoff<br />

to protect the reputation of its trademark by identifying counterfeits<br />

and by protecting against defects,” Davidoff was likely to succeed<br />

in its trademark infringement claim and a preliminary injunction<br />

accordingly was appropriate. 4<br />

The Second Circuit held that to establish a Lanham Act violation<br />

there need not be actual quality differences between the authorized<br />

goods and the gray-market goods — instead, the Lanham Act<br />

affords the trademark owner the right to control the quality of goods<br />

manufactured and sold bearing the mark. 5 The court endorsed the<br />

three-part test set forth in Warner-Lambert Co. v. Northside Development<br />

Corp., 6 to determine whether a holder’s right to control quality<br />

has been subverted:<br />

[A] trademark holder is entitled to an injunction against<br />

one who would subvert its quality control measures<br />

upon a showing that (i) the asserted quality control<br />

procedures are established, legitimate, substantial,<br />

and nonpretextual, (ii) it abides by these procedures,<br />

and (iii) sales of products that fail to conform to these<br />

procedures will diminish the value of the mark. 7<br />

The appellate court determined that Davidoff’s practice of regularly<br />

working with and training retailers, private investigators and U.S.<br />

Customs agents enhanced its effectiveness to detect and prevent<br />

the sales of counterfeits and to detect and recall defective goods; all<br />

of which worked toward meeting the first two prongs of the Warner<br />

test. 8 CVS argued that Davidoff’s UPC system is only a pretextual<br />

quality control mechanism and in reality its true purpose is to allow<br />

Davidoff to search out distributors of gray-market goods. The court,<br />

however, found the argument to be unconvincing based on evidence<br />

provided by Davidoff that it had in fact used its UPC system on<br />

many occasions to address quality control issues such as identifying<br />

counterfeits, under-filled or over-filled bottles, defective dispensers<br />

and improper packaging. 9<br />

In discussing the third prong, the appellate court noted that Davidoff<br />

is able to use the UPC system to identify counterfeit items by<br />

discovering items with UPCs that are not registered on its system. 10<br />

Although CVS argued that gray-market goods are not necessarily<br />

counterfeit goods, the court noted that gray-market goods that have<br />

the UPC removed make it almost impossible for trademark holders<br />

like Davidoff to discover counterfeit goods. 11 The court stated that<br />

anti-counterfeiting systems control — even if indirectly — the quality<br />

of a product because counterfeit goods are invariably inconsistent<br />

and lower in quality. 12<br />

Regarding direct quality control, the court found that the UPC<br />

system helps Davidoff to identify and recall genuine authorized but<br />

defective products. The UPC helps to identify where a product was<br />

manufactured and the batch which produced the defect, and helps<br />

facilitate targeted recall. Removing the UPC from a product could<br />

prevent Davidoff from tracking the instances of inconsistency and<br />

defect among its genuine fragrances. This interference alone, the<br />

court held, is a violation of Davidoff’s right as trademark holder to<br />

control the quality of its product. 13<br />

( continued on page 8 )


( continued from page 7 )<br />

Impact<br />

For the luxury manufacturer, this case signifies that anti-counterfeiting<br />

systems can constitute quality control procedures. Tampering with<br />

those systems could interfere with a trademark holder’s right to<br />

control the quality of its product and maintain the value of its mark,<br />

and such conduct in and of itself may constitute trademark infringement,<br />

at least in the Second Circuit. In light of this decision, luxury<br />

item manufacturers that utilize a UPC-like system for their products<br />

may be successful in seeking a preliminary injunction in the Second<br />

Circuit against retailers that resell even genuine products but do so<br />

by obfuscating or removing UPCs. �<br />

1 Zino Davidoff SA v. CVS Corp., 2009 U.S. App. LEXIS 13172 (2d Cir. N.Y. June 19,<br />

2009).<br />

2 E.g., Enesco Corp. v. Price/Costco Inc., 146 F.3d 1083, 1085 (9th Cir. 1998).<br />

3 See Davidoff & Cie v. PLD International Corporation, 263 F.3d 1297, 1303 (11th Cir.<br />

2001) (a defacement of UPCs on a bottle that “degrades the appearance” of the<br />

product may constitute trademark infringement).<br />

4 Id. at 2.<br />

5 El Greco Leather Products v. Shoe World, Inc., 806 F.2d 392, 395 (2d Cir. 1986)<br />

(emphasis added).<br />

6 86 F.3d 3, 39 (2d Cir. 1996).<br />

7 Zino Davidoff, 2009 U.S. App. LEXIS 13172 at *16.<br />

8 Id. But note that Warner-Lambert involved product that was being sold beyond its<br />

expiry date, and accordingly arguably no longer was genuine.<br />

9 Id. at *18.<br />

10 Id. at *14.<br />

11 Id. at *17.<br />

12 Id. at *15.<br />

13 Id. at *17-19.<br />

Federal Circuit Issues Two Key Decisions<br />

Clarifying Rights of Patent Licensees<br />

On May 22, 2009, the Federal Circuit issued two decisions clarifying<br />

the scope of rights conferred by patent license agreements, ruling in<br />

favor of the patent licensee in both cases. In the first, Epistar Corp.<br />

v. Int’l Trade Comm’n, Case No. 2007-1457, the court held that a<br />

covenant not to challenge patent validity in a settlement or license<br />

agreement was binding against successors-in-interest only to the<br />

extent that it could have been enforced against the original licensee.<br />

As such, a future assignee of a patent license retains the right to<br />

assert a defense of patent invalidity in contexts that are outside the<br />

scope of the original license agreement. In the second decision,<br />

CoreBrace LLC v. Star Seismic LLC, Case No. 2008-1502, the court<br />

determined that a license to make, use, and sell a patented product<br />

necessarily included an implied license to have that product made<br />

by a third party. Both of these decisions will undoubtedly impact<br />

the legal and commercial analyses that business entities must<br />

undertake when entering into agreements or considering corporate<br />

mergers or acquisitions.<br />

Epistar Corp. v. Int’l Trade Comm’n<br />

On November 4, 2005, Philips Lumileds Lighting Company<br />

(Lumileds) alleged infringement of U.S. Patent No. 5,008,718 (the<br />

‘718 patent) against Epistar Corporation (Epistar) and United Epitaxy<br />

Company (UEC) in the International Trade Commission (ITC). Prior<br />

IP® EVIEW<br />

8<br />

to the filing of that action, Lumileds had entered into two separate<br />

license agreements with Epistar and UEC, respectively, which<br />

covered some (but not all) of the products manufactured by these<br />

two entities. The license with UEC included the right to use the ‘718<br />

patent for the manufacture, sale and importation of light emitting<br />

diodes, and also contained a covenant not to challenge the ‘718<br />

patent’s validity. The license with Epistar, covering a different set of<br />

products, preserved Epistar’s right to challenge validity with respect<br />

to any Epistar products that might later be accused of infringement.<br />

Two months after the ITC action was filed, UEC merged into Epistar,<br />

with UEC ceasing to exist as a separate company, and with Epistar<br />

assuming all of “UEC’s assets, liabilities, contractual and patent-<br />

related rights and obligations, and UEC’s status as a party to the<br />

Commission investigation,” including UEC’s license with Lumileds.<br />

After the merger, Epistar continued to manufacture its own light<br />

emitting diodes, along with UEC’s products and three next-generation<br />

diode products.<br />

The ITC found that “Epistar, like UEC, is barred from raising an<br />

invalidity defense to the assertion of infringement of the ‘718 patent<br />

against any product” because “Epistar, like UEC, would be contractually<br />

estopped from raising an invalidity defense to the ‘718 patent.”<br />

The Federal Circuit reversed this finding, holding that “Epistar (as<br />

successor to UEC) may not contest the validity of the ‘718 patent<br />

with respect to the UEC products that it inherited in the merger,”<br />

but this restriction would have no effect on Epistar’s right to challenge<br />

the ‘718 patent when other products are at issue. As such,<br />

“Epistar’s acquisition of UEC does not have the effect of limiting<br />

Epistar’s rights that are unrelated to the product lines it acquired<br />

from UEC.”<br />

While this case involves some unique circumstances, including<br />

the fact that Epistar had its own license agreement with Lumileds<br />

which contained no covenant against challenging validity, the court’s<br />

analysis suggests that its ruling applies to a broad range of commercial<br />

relationships. For instance, the court notes that “[b]lack letter<br />

contract law states that the assignment of a contract to an assignee,<br />

such as from UEC to Epistar, only changes the obligated party, not<br />

the scope of the obligation.” Given these underlying principles, it<br />

appears that even if there had been no separate agreement preserving<br />

the right to contest validity, the merger of UEC and Epistar<br />

would not have eliminated Epistar’s ability to challenge the validity of<br />

the ‘718 patent in all contexts.<br />

CoreBrace LLC v. Star Seismic LLC<br />

In CoreBrace, defendant Star Seismic LLC (Star) had received a<br />

license in 2007 to U.S. Patent No. 7,188,452 (the ‘452 patent) from<br />

the predecessor-in-interest to plaintiff CoreBrace LLC (CoreBrace).<br />

On January 4, 2008, CoreBrace sent a letter to Star stating that<br />

the license was terminated based upon Star’s use of third-party<br />

contractors to manufacture licensed products for Star’s own use,<br />

which CoreBrace contended was a breach of the license. On that<br />

same day, CoreBrace filed suit for patent infringement. The district<br />

court granted a Rule 12(b)(6) motion to dismiss, after determining<br />

that Star was entitled to use third-party contractors to make the<br />

licensed products, without such action constituting a breach of<br />

the license.<br />

The Federal Circuit affirmed the district court’s dismissal, concluding<br />

that “[t]he right to ‘make, use, and sell’ a product inherently includes<br />

the right to have it made by a third party, absent a clear indication<br />

( continued on page 9 )


( continued from page 8 )<br />

of intent to the contrary.” Although the case nominally involved the<br />

application of Utah’s contractual laws, the Federal Circuit’s holding<br />

was based broadly on what it identified as complete agreement<br />

among courts that had considered analogous circumstances, “that a<br />

‘have made’ right is implicit in a right to make, use, and sell, absent<br />

an express contrary intent.” Indeed, the Federal Circuit reached<br />

this conclusion despite the fact that the licensee between Star and<br />

CoreBrace included a “reservation of rights” clause. Thus, without<br />

a showing of “clear intent to exclude ‘have made’ rights from the<br />

License,” a patent licensor cannot sue for infringement based upon<br />

the actions of a third party who is manufacturing licensed products<br />

on behalf of the licensee.<br />

Importance of Epistar and CoreBrace<br />

Each of these decisions offers considerable guidance to commercial<br />

entities when drafting agreements and when assessing<br />

the intellectual property aspects of contemplated mergers and<br />

acquisitions. In both of these cases, the licensee “won” — but in<br />

each case, the Federal Circuit’s opinion suggests that a different<br />

outcome could have been reached had the license agreements at<br />

issue been drafted differently. Thus, these cases offer crucial guidance<br />

and clarity to parties on both sides of a potential or existing<br />

license agreement.<br />

Commercial entities must be cognizant that a covenant against<br />

challenging patent validity ultimately may not be enforceable in<br />

all contexts against a license assignee. This will undoubtedly<br />

affect the valuation of potential targets and the likelihood that the<br />

acquiring party will one day be held liable for patent infringement<br />

of a valid claim. In addition, when drafting license agreements,<br />

parties must be aware of the scope and limitations of any covenants<br />

made on behalf of the licensee, which the Federal Circuit<br />

has indicated will be strictly interpreted, at least in the context of<br />

a merger.<br />

Likewise, the Federal Circuit also has created a brightline rule with<br />

respect to the manufacturing of licensed products by third parties<br />

— there must be a clear indication that the license does not extend<br />

to such third-party activities; a reservation of rights clause is insufficient.<br />

This may require parties on both sides of license agreements<br />

(or potential license agreements) to discuss issues of third-party<br />

manufacturing and assess whether this issue should be explicitly<br />

addressed in the agreement. �<br />

ISPs Immunity From Contributory<br />

Infringement Not Absolute<br />

Courts in the United States repeatedly have failed to hold Internet<br />

service providers (ISPs) liable for contributory infringement based on<br />

their hosting of Web sites — until now. In Louis Vuitton Malletier,<br />

S.A. v. Akanoc Solutions, Inc., et al., 1 a jury in the Northern District<br />

of California found two ISPs liable for $32.4 million in damages for<br />

contributory trademark and copyright infringement when they failed<br />

to take down sites selling counterfeit goods. This verdict presents<br />

both an opportunity for brand owners seeking to stop the distribution<br />

of infringing goods on the Internet, and an area of vulnerability for<br />

ISPs that host sites offering such goods. It also creates a distinction<br />

between how courts in the Second Circuit and the Ninth Circuit view<br />

such activities.<br />

IP® EVIEW<br />

9<br />

Background<br />

The plaintiff, Louis Vuitton Malletier, S.A. (LV or the company), is a<br />

well-known designer and distributor of luxury handbags, luggage<br />

and other leather goods best known for bearing the distinctive “LV”<br />

trademark. Within the United States, the company is the sole and<br />

exclusive distributor of its products, which it sells online through a<br />

single Web site operated by the company. 2<br />

The defendants, Akanoc Solutions, Inc. (Akanoc) and Managed<br />

Solutions Group, Inc. (MSGI) are ISPs that sell IP addresses and host<br />

Web sites. A third defendant, Steven Chen, owns, operates and<br />

controls both Akanoc and MSGI. According to LV, most, if not all, of<br />

the Web sites hosted by the defendants are engaged in the sale of<br />

counterfeit merchandise. 3<br />

In 2006 and 2007, LV learned that over 70 Web sites hosted on the<br />

defendants’ servers were selling counterfeit goods bearing “LV”<br />

trademarks. 4 For a period of more than six months, the company<br />

sent the defendants numerous letters demanding that the Web sites<br />

be taken down. The defendants failed to respond to any of LV’s<br />

requests and thus the majority of the offending Web sites were not<br />

taken offline until after LV filed a lawsuit. 5<br />

The company brought an action in federal district court alleging (1)<br />

contributory trademark infringement; (2) vicarious trademark infringement;<br />

(3) contributory copyright infringement; and (4) vicarious<br />

copyright infringement. The district court granted the defendants’<br />

motion for summary judgment on the vicarious infringement<br />

claims, but denied it with respect to the contributory trademark and<br />

copyright infringement claims, finding there was evidence that the<br />

defendants had actual knowledge of, and continued to support, the<br />

counterfeiting Web sites.<br />

The Jury’s Verdict<br />

After a trial on the merits, the jury found all three defendants liable<br />

for contributory trademark and copyright infringement. Specifically,<br />

the jurors found that after repeated notices from LV, defendants<br />

knew or should have known that customers were using their services<br />

to infringe LV’s intellectual property. Instead of taking action to<br />

stop such activities by ceasing to host the Web sites, the defendants<br />

ignored the requests and continued to provide the services, thereby<br />

contributing to the damages suffered by LV.<br />

The jury further rejected the defendants’ arguments that the safe harbor<br />

provisions of the Digital Millennium Copyright Act (DMCA) insulated<br />

them from liability. The DMCA holds ISPs whose services are used<br />

to commit infringement 6 immune from legal liability for such activities<br />

when they establish and follow a “notice and takedown” process<br />

to respond to complaints and remove infringing material in a timely<br />

manner. It does not, however, protect an ISP that is “aware of facts or<br />

circumstances from which infringing activity is apparent” or “receive[s]<br />

a financial benefit directly attributable to the infringing activity.” 7 As<br />

discussed above, the jury was convinced that the defendants were<br />

aware of the infringing activity and rather than stop it, instead chose to<br />

continue to receive hosting fees and enable the infringement.<br />

In determining damages, the jury found that the defendants acted<br />

willfully, and thus awarded LV $31.5 million on the contributory<br />

trademark and $900,000 on the contributory copyright infringement<br />

claims. The district court is expected to issue a permanent injunction<br />

prohibiting defendants from hosting Web sites selling counterfeit<br />

Louis Vuitton goods.<br />

( continued on page 10 )


( continued from page 9 )<br />

Split in the Circuits’ Views<br />

Prior to the Louis Vuitton case, ISPs generally were well shielded by<br />

judicial interpretations of the DMCA’s safe harbor. Additionally, no<br />

court or jury previously had found an ISP liable for contributory trademark<br />

infringement where customers used the ISP’s services to sell<br />

counterfeit or infringing goods. In fact, in July 2008, the U.S. District<br />

Court for the Southern District of New York held in Tiffany, Inc. v.<br />

eBay, Inc., 8 a case with certain similar facts, that online marketplace<br />

eBay, Inc. was not liable for contributory trademark infringement.<br />

The case is on appeal to the U.S. Court of Appeals for the Second<br />

Circuit, which heard oral arguments in July 2009.<br />

In Tiffany v. eBay, after conducting a bench trial on the merits, the<br />

court was not convinced that luxury jeweler Tiffany, Inc.’s repeated<br />

mailing of demand letters to eBay and its submission of eBay’s<br />

Notice of Claimed Infringement (NOCI) forms notifying eBay that<br />

counterfeit Tiffany products were sold on its marketplace were<br />

sufficient to establish eBays’ knowledge of the infringement. The<br />

court determined that Tiffany’s demand letters only gave eBay generalized<br />

knowledge rather than knowledge of specific instances of<br />

infringement, and thus were not sufficient to establish a contributory<br />

trademark infringement claim. As discussed above, this is in direct<br />

contrast to the Louis Vuitton case, where the jury believed that LV’s<br />

demand letters were sufficient to find that the defendants knew or<br />

should have known of specific instances of infringement.<br />

Another fact worth noting is the difference in the respective<br />

defendants’ responses to the plaintiffs’ demand letters. In Tiffany<br />

v. eBay, the defendant maintained extensive anti-fraud measures<br />

and responded to each of Tiffany’s NOCI forms by investigating and<br />

ultimately removing the listings for counterfeit goods. Therefore,<br />

the court concluded that, even assuming the demand letters could<br />

constitute specific knowledge, the defendant took prompt steps to<br />

stop the infringement. In contrast, the defendants in Louis Vuitton<br />

did not respond to the demand letters and failed to promptly cease<br />

hosting the sites selling counterfeit goods.<br />

Impact<br />

It will be interesting to see if and how the Ninth and Second Circuits<br />

resolve their different approaches to the issue of sufficient notice<br />

under the DMCA. In the meantime, the jury’s verdict in Louis<br />

Vuitton could create a helpful new avenue for companies struggling<br />

to protect their brands and intellectual property from infringement on<br />

the Internet. In light of the case, intellectual property owners should<br />

not only notify ISPs of infringement, but continue to send demand<br />

letters to nonresponsive ISPs, as courts may view such actions as<br />

evidence of contributory infringement. The case also should serve<br />

as a reminder for ISPs that the safe harbor protections of the DMCA<br />

are not absolute. Turning a blind eye toward intellectual property<br />

owners’ take-down requests may render an ISP liable for willful<br />

contributory infringement and subject it to large damage awards. �<br />

1 Verdict, Louis Vuitton Malletier, S.A. v. Akanoc Solutions, Inc., et al., No. C 07-03952<br />

JW (N.D. Cal. Aug. 28, 2009).<br />

2 See Amended Complaint, supra note 1, at 8-9.<br />

3 See id. at 31.<br />

4 See Order Granting in Part and Denying in Part Defendants’ Motion for Summary<br />

Judgment, supra note 1, at 2-3.<br />

5 See Declaration of Nikolay Livadkin in Support of Opposition to Defendants’ Motion<br />

for Summary Judgment, supra note 1, at 12-19.<br />

IP® EVIEW<br />

10<br />

6 See 17 U.S.C. § 512 (2008).<br />

7 Id. § 512(c)(1).<br />

8 576 F. Supp. 2d 463 (S.D.N.Y. 2008), appeal docketed, No. 08-3947-cv (2d Cir. filed<br />

Aug. 11, 2008).<br />

SEC Imposes $100,000 Fine for Firm’s Failure<br />

to Safeguard Customer Information<br />

The Securities and Exchange Commission (SEC) recently intensified<br />

its efforts to ensure that firms implement adequate measures<br />

to protect customers’ nonpublic personal information. On September<br />

29, 2009, the SEC issued a cease and desist order pursuant<br />

to Sections 15(b) and 21C of the Securities Exchange Act of 1934,<br />

and Sections 203(e) and 203(k) of the Investment Advisers Act of<br />

1940 against a registered broker-dealer/investment adviser that<br />

failed to safeguard customer information. 1 The SEC also ordered<br />

the firm, Commonwealth Equity Services, LLP d/b/a Commonwealth<br />

Financial Network (Commonwealth), to pay a civil money<br />

penalty of $100,000.<br />

Background<br />

Rule 30(a) of Regulation S-P (the Safeguards Rule) 2 requires brokerdealers<br />

and SEC-registered investment advisers to adopt written<br />

policies and procedures that address administrative, technical and<br />

physical safeguards for the protection of customer records and information.<br />

Specifically, these written policies and procedures must be<br />

reasonably designed to: (1) ensure the security and confidentiality of<br />

customer records and information; (2) protect against any anticipated<br />

threats or hazards to the security or integrity of customer records<br />

and information; and (3) protect against unauthorized access to or<br />

use of customer records or information that could result in substantial<br />

harm or inconvenience to any customer. 3<br />

Commonwealth retains approximately 1,600 licensed brokers<br />

as independent contractors (registered representatives). Each<br />

registered representative received Commonwealth’s written policies<br />

and procedures, which were intended to safeguard customer<br />

records and information. These policies required each representative<br />

to maintain the security of the information entrusted to that<br />

representative. In connection with such requirement, the policies<br />

recommended that the registered representatives install anti-virus<br />

software on computers used by the representatives to access<br />

customer account information.<br />

In November 2008, an unauthorized party hacked into a registered<br />

representative’s computer, obtained the representative’s login<br />

credentials and used the credentials to access customer account<br />

information. The intruder then entered several unauthorized purchase<br />

orders for which Commonwealth absorbed monetary losses.<br />

Notably, the representative whose computer was hacked had called<br />

Commonwealth’s IT help desk several times before the incident.<br />

For example, in September 2008, the representative called the help<br />

desk for assistance with a potential software virus. The help desk<br />

was unable to detect anti-virus software on the representative’s<br />

computer, but only “recommended” that the representative install<br />

such software. The help desk did not do any follow up, and the<br />

representative never installed the software. The lack of anti-virus<br />

software allowed the intruder to hack the representative’s computer<br />

and access customer information.<br />

( continued on page 11 )


( continued from page 10 )<br />

In anticipation of the SEC proceedings, Commonwealth submitted<br />

an Offer of Settlement. The SEC accepted Commonwealth’s offer<br />

and entered the order instituting administrative and cease and desist<br />

proceedings. Commonwealth consented to the order without admitting<br />

or denying any of the findings in the order.<br />

SEC Order<br />

The SEC found that Commonwealth willfully violated the Safeguards<br />

Rule by recommending, but not requiring, that its registered representatives<br />

maintain anti-virus software on their computers. As a<br />

result, Commonwealth’s customer information was left vulnerable,<br />

and such vulnerability was successfully exploited.<br />

Commonwealth also was found not to have procedures in place to<br />

adequately review its representatives’ computer security measures.<br />

In particular, Commonwealth did not audit its representatives’<br />

computers to determine whether anti-virus software was installed.<br />

Additionally, Commonwealth did not have procedures in place to<br />

follow up on potential computer security issues uncovered during<br />

audits or when representatives notified Commonwealth of the issue.<br />

Impact<br />

The SEC order against Commonwealth comes at a time when<br />

state and federal regulators are paying increased attention to data<br />

breaches, and serves as an important reminder that firms must pay<br />

careful attention to this area. The order reiterates that companies<br />

are not only responsible for their own systems, but for the systems<br />

of independent contractors, even where independent contractors<br />

provide their own computer and software. Firms must also ensure<br />

that their security measures protect against unauthorized access to<br />

customer records, and must implement policies to address security<br />

issues that arise. In particular, firms registered with the SEC must<br />

put these procedures in writing to ensure compliance with the<br />

Safeguards Rule. �<br />

1 See Release No. 34-60733.<br />

2 17 C.F.R. A7 248.30(a). The Safeguards Rule became effective on November 13,<br />

2000, and compliance has been mandatory since July 1, 2001.<br />

3 Id.<br />

The Reign of Bilski ( from page 1 )<br />

The Bilski Decision<br />

The Federal Circuit’s en banc decision arose from a patent application<br />

with claims directed to methods of hedging risk in the field of<br />

commodities trading. During prosecution, all of the pending claims<br />

were rejected by the Patent Office (PTO) under Section 101 of the<br />

Patent Act. Section 101 provides that:<br />

Whoever invents or discovers any new and useful<br />

process, machine, manufacture, or composition of<br />

matter, or any new and useful improvement thereof, may<br />

obtain a patent therefor, subject to the conditions and<br />

requirements of this title.<br />

35 U.S.C. § 101. Section 101 recites four categories of patenteligible<br />

subject matter: processes, machines, manufactures and<br />

compositions of matter. Although the applicants contended that<br />

IP® EVIEW<br />

11<br />

their claims were directed to a “new and useful process,” the PTO<br />

and the Board of Patent Appeals and Interferences (BPAI) disagreed.<br />

Upon appeal, the en banc Federal Circuit affirmed the rejection of the<br />

pending claims, with nine circuit judges joining the majority opinion,<br />

two judges filing dissenting opinions agreeing with the ultimate outcome<br />

but offering a different rational, and one judge filing a lengthy<br />

dissent without expressing a view as to whether the claims were<br />

drawn to patent-eligible subject matter under Section 101. Despite<br />

the multiple opinions, the Federal Circuit judges all agreed, following<br />

prior decisions of the Supreme Court, that the meaning of the term<br />

“process” in Section 101 is narrower than its ordinary meaning.<br />

“Specifically, the Court has held that a claim is not a patent-eligible<br />

‘process’ if it claims ‘laws of nature, natural phenomena, [or] abstract<br />

ideas.’” Bilski, 545 Fed. Cir. at 952 (quoting Diamond v. Diehr, 450<br />

U.S. 175, 185 (1981)). However, the various opinions debated what<br />

test or set of criteria governed the determination as to when a process<br />

was improperly claiming a law of nature, natural phenomena,<br />

mental process or an abstract idea.<br />

The majority opinion set forth the following test in an attempt to<br />

answer that question. The Federal Circuit held that a “claimed<br />

process is surely patent-eligible under Section 101 if: (1) it is tied<br />

to a particular machine or apparatus, or (2) it transforms a particular<br />

article into a different state or thing.” Bilski, 545 F.3d at 954<br />

(emphasis in original). The court explained that “the use of a specific<br />

machine or transformation of an article must impose meaningful<br />

limits on the claim’s scope to impart patent-eligibility” and “the<br />

involvement of the machine or transformation in the claimed process<br />

must not merely be insignificant extra-solution activity.” Id. at<br />

961-62. Thus, the transformation of a particular article into a different<br />

state or thing “must be central to the purpose of the claimed<br />

process.” Id. In further explaining the “machine-or-transformation”<br />

test, the Federal Circuit explained that “mere field-of-use limitations<br />

are generally insufficient to render an otherwise ineligible process<br />

claim patent-eligible,” as such limitations indicate that a claim is not<br />

limited to a specific application of a fundamental principle. Id. at 957.<br />

The Federal Circuit’s “machine-or-transformation” test was adopted<br />

to the exclusion of the Freeman-Walter-Abele test 1 , the “useful,<br />

concrete and tangible result” test 2 , and a “technological arts” test<br />

proposed by several amici.<br />

Applying the machine-or-transformation test, the Federal Circuit<br />

held that the applicants’ claims failed to satisfy the first prong of<br />

the test (process tied to a particular machine) as the applicants<br />

admitted that their pending claims were not limited to any specific<br />

machine or apparatus. Id. at 962. The Federal Circuit also held<br />

that the applicants’ claims did not transform any article to a different<br />

state or thing. In particular, the Federal Circuit held that<br />

manipulation of “legal obligations or relationships, business risks,<br />

or other such abstractions cannot meet the test because they are<br />

not physical objects or substances, and they are not representative<br />

of physical objects or substances.” Id. at 963. In short, the<br />

applicants’ claims were rejected since they sought “to claim a nontransformative<br />

process that encompasses a purely mental process<br />

of performing requisite mathematical calculations without the aid of<br />

a computer or any other device, mentally identifying those transactions<br />

that the calculations have revealed would hedge each other’s<br />

risks, and performing the post-solution step of consummating<br />

those transactions.” Id. at 965. With this decision, the Federal<br />

Circuit opened the door to a greater number of invalidity challenges<br />

based on Section 101.<br />

( continued on page 12 )


( continued from page 11 )<br />

Post-Bilski Decisions by the Federal Circuit<br />

Although not mentioning Bilski, the Federal Circuit applied Section<br />

101 to affirm the rejection of a large number of claims directed to<br />

methods for mandatory arbitration in In re Comiskey, 554 F.3d 967<br />

(Fed. Cir. 2009). In particular, the rejected claims recited methods<br />

or systems for mandatory arbitration involving legal documents. The<br />

claims did not require the use of a mechanical device such as a computer.<br />

After addressing prior Section 101 jurisprudence, the Federal<br />

Circuit reiterated that the term “process” as used in the Patent<br />

Act did not actually encompass all things that could be considered<br />

processes. The Federal Circuit held that Comiskey’s method claims<br />

were not patent-eligible because they recited business systems that<br />

depended entirely on the use of mental processes and abstract ideas.<br />

In its first decision subsequent to Bilski that applied the machineor-transformation<br />

test, the Federal Circuit confirmed the rejection<br />

of claims directed to methods of marketing products and claims<br />

directed to “paradigms” for marketing. See In re Ferguson, 558<br />

F.3d 1359 (Fed. Cir. 2009). The Federal Circuit held that the<br />

methods for marketing did not satisfy either prong of the machineor-transformation<br />

test and reiterated that this was the sole test for<br />

judging the patent eligibility of method claims. 3 The methods were<br />

not tied to any particular machine or apparatus (“a marketing force<br />

is not a machine”). Id. at 1364. Furthermore, the methods did not<br />

transform any article into a different state or thing — organizing<br />

business or legal relationships in the structuring of a sales force is<br />

not transforming a physical object or substance. Id. With regard<br />

to the “paradigm” claims, the Federal Circuit rejected those claims<br />

as covering nonstatutory subject matter in that they only provided<br />

an abstract idea — “a business model for an intangible marketing<br />

company.” Id. at 1366.<br />

In its most recent decision applying Section 101, the Federal Circuit<br />

reversed a district court’s determination that claims directed to a<br />

method of optimizing therapeutic efficacy for a particular disorder<br />

were invalid as directed to nonstatutory subject matter. In Prometheus<br />

Labs., Inc. v. Mayo Collaborative Servs., 581 F.3d 1336,<br />

2009 U.S. App. LEXIS 20623 (Fed. Cir. Sept. 16, 2009), the claims at<br />

issue were directed to methods of optimizing treatment comprising the<br />

steps of (1) administering a particular drug to a subject (“providing<br />

6-thioguanine”) and (2) determining the level of certain metabolites<br />

in the subject as a result of the administering step. The claims<br />

also recited several “wherein” clauses that suggested, but did not<br />

require, either a need to increase or decrease further administration<br />

of the drug based on the determining step.<br />

Applying the machine-or-transformation test, the Federal Circuit held<br />

that the claims were patent-eligible because they transformed an<br />

article into a different state or thing. “The transformation is one of<br />

the human body following administration of a drug and the various<br />

chemical and physical changes of the drug’s metabolites that enable<br />

their concentrations to be determined.” Prometheus Labs., 2009<br />

U.S. App. LEXIS 20623 at *22-23. The Federal Circuit indicated that<br />

administering drugs as a method of treatment is “always transformative”<br />

when attempting to treat the effects of a medical condition. Id.<br />

at *23. The Federal Circuit rejected the notion that the administering<br />

and determining steps amounted to mere data gathering and as such<br />

did not fall within the scope of patentable subject matter. Instead,<br />

the steps were considered to be “part of a treatment protocol”<br />

and as such were transformative. Id. at *28. With regard to the<br />

“wherein” clauses, the Federal Circuit held that those statements<br />

did not render the claims outside the scope of the Patent Act even<br />

IP® EVIEW<br />

12<br />

though they suggested mental processes used to determine the<br />

need to change drug dosage levels in the future. Reiterating its<br />

discussion in Bilski, the Federal Circuit noted that it is irrelevant<br />

whether any individual step or limitation in a process claim would be<br />

unpatentable by itself. Id. at *30-31. When the claims are viewed<br />

as a whole, the mental steps recited in the “wherein” clauses did<br />

not negate the transformative aspects of the “administering” and<br />

“determining” steps in the claim. Id. at *30-32. 4<br />

Post-Bilski Decisions by District Courts<br />

Following the example set by the Federal Circuit, several district<br />

court decisions demonstrate that district court judges are willing<br />

to find claims invalid under Section 101 when they do not meet<br />

the “machine-or-transformation” test. In Fort Properties, Inc. v.<br />

American Master Lease, LLC, 609 F. Supp. 2d 1052 (C.D. Cal. 2009),<br />

the court held that all claims of a patent directed to methods of<br />

conducting transactions for acquiring real estate were invalid under<br />

Section 101. Since the applicant admitted during prosecution that<br />

the methods could be performed without the use of a computer, the<br />

court proceeded to review whether the claims met the transformation<br />

prong of the Bilski test. “Like the claims at issue in Bilski,<br />

the claims of the ‘788 Patent involve only the transformation or<br />

manipulation of legal obligations and relationships. Specifically,<br />

the claims of the ‘788 Patent only transform or manipulate legal<br />

ownership interests in real estate. Under Bilski, the Court cannot<br />

find that those claims transform an article or thing.” Fort Properties,<br />

609 F. Supp. 2d at 1056. 5 While the claims did recite the creation of<br />

“deedshares,” the court held that the deedshares were not physical<br />

objects, but instead were conceptual legal rights that may or may not<br />

be printed on paper. Id.<br />

In Cybersource Corp. v. Retail Decisions, Inc., 620 F. Supp. 2d 1068<br />

(N.D. Cal. 2009), the district court held that two claims — one<br />

directed to a method for verifying the validity of credit card transactions<br />

“over the Internet,” and another claim directed to a “computerreadable<br />

medium containing program instructions for detecting fraud<br />

in a credit card transaction” — were invalid under Section 101. In<br />

invalidating the method claim, the court determined that “manipulation”<br />

of credit card numbers to construct a data structure useful in<br />

detecting fraud was not patent-eligible. “There is no indication that<br />

the Federal Circuit, having reaffirmed the machine-or-transformation<br />

test, intended to weaken the key term ‘transformation’ by equating<br />

it with mere ‘manipulation.’” Cybersource Corp., 620 F. Supp. 2d at<br />

1073. The court determined that neither the credit card numbers<br />

nor the credit cards were “transformed.” “Simply collecting data<br />

into a vague sort of ‘map’ does not amount to a ‘transformation.’”<br />

Id. at 1074. Furthermore, the court held that the credit card number<br />

represented an account and not a physical object: “Both the number<br />

and the card represent a common underlying abstraction — a credit<br />

card account, which is a series of rights and obligations existing<br />

between an account holder … and a card issuer.” Id. Analogizing this<br />

to Bilski, the court commented that a “piece of paper upon which the<br />

terms of an option are written is, like a credit card, a physical object.<br />

Yet this connection to a physical medium does not create patent<br />

eligibility, because an option ultimately represents the abstraction of a<br />

legal obligation or business risk. … Like options or deedshares, credit<br />

card accounts represent sets of legal rights and relationships, not<br />

‘articles.’” Id.<br />

The method claim in Cybersource Corp. was held invalid notwithstanding<br />

that it recited steps for use “over the Internet” and utilized<br />

“an Internet address” as part of a method for verifying the validity of<br />

( continued on page 13 )


( continued from page 12 )<br />

a transaction. The district court held that the claimed method was<br />

not statutory as the method did not transform or manipulate an IP<br />

address. “The IP address itself is not an object of transformation;<br />

indeed, it would make no sense to change the IP address, since its<br />

purpose is to serve as an identifier.” Id. at 1076.<br />

The “computer-readable medium” claim contained the same limitations<br />

regarding credit card numbers and the use of IP addresses. It<br />

also recited the use of “one or more processors” to carry out certain<br />

steps. Nonetheless, the court held that this claim was invalid because<br />

it was not implemented on a particular machine. The court rejected<br />

the idea that the “Internet” was a particular machine: “the internet is<br />

an abstraction. If every computer user in the world unplugged from<br />

the internet, the internet would cease to exist, although every molecule<br />

of every machine remained in place. One can touch a computer or a<br />

network cable, but one cannot touch ‘the internet.’” Id. at 1077. The<br />

court also concluded that the use of the “Internet” was insignificant<br />

extra-solution activity and constituted an attempt to make nonstatutory<br />

subject matter patent-eligible simply by limiting the claim to a particular<br />

technological field. Id. at 1077-78. Finally, the court held that simply<br />

adding the phrase “a computer-readable medium” to an otherwise nonstatutory<br />

process claim is insufficient to make it statutory. Id. at 1079.<br />

In Every Penny Counts, Inc. v. Bank of America Corp., 2009 U.S.<br />

Dist. LEXIS 53626 (M.D. Fla. May 27, 2009), the claim at issue<br />

concerned a “system,” including a network with various means for<br />

accomplishing certain tasks (e.g., “entry means … for entering into<br />

the network an amount being paid in a transaction”). The patentee<br />

argued that since the claim was directed to a “system” containing<br />

several “means,” the claim was directed to a machine — a category<br />

of patentable subject matter not addressed by Bilski. Despite the<br />

language of the claim, the court held that the patent was directed<br />

to a process and not a machine. According to the district court,<br />

the claim was directed to “a mathematical algorithm [that] uses<br />

machines for data input and data output and to perform the required<br />

calculations. Those machines do not, however, impose any limit on<br />

the process itself. The involvement of the machine in the process<br />

is insignificant extra-solution activity and thus the process is not<br />

patentable under § 101.” Every Penny Counts, 2009 U.S. Dist.<br />

LEXIS 53626 at *7. The court held that the steps of the claim did not<br />

transform any article into something different, and that the process<br />

was not tied to a particular computer or other device. Id. at *8.<br />

Accordingly, the court held the claim invalid under Section 101.<br />

In DealerTrack, Inc. v. Huber, 2009 U.S. Dist. LEXIS 58125 (C.D. Cal.<br />

July 7, 2009), the court held that patent claims directed to computeraided<br />

methods of managing credit applications were invalid under<br />

Section 101. The sole question concerned whether the method<br />

claims were tied to a particular machine, as the plaintiff apparently<br />

conceded that the transformation prong of Bilski was not met. Id.<br />

at *8-9. The claims at issue did recite a “computer aided method,”<br />

including receiving data from “a remote application entry and display<br />

device” and forwarding that data “to remote funding source terminal<br />

devices.” Nonetheless, the court held that the claims were invalid<br />

because “none of these devices constitutes a ‘particular machine’<br />

within the meaning of Bilski.” Id. at *12. Referencing its earlier<br />

claim construction ruling, the court noted that the “remote application<br />

entry” device and “remote funding” devices included any device<br />

“such as a personal computer or dumb terminal, and these devices<br />

clearly cannot constitute particular machines.” Id. at *13. 6<br />

In Research Corp. Technologies, Inc. v. Microsoft Corp., 2009 U.S.<br />

Dist. LEXIS 71883 (D. Az. July 28, 2009), the court rendered a<br />

IP® EVIEW<br />

13<br />

split decision, holding two patents invalid under Section 101, but<br />

confirming the patentability of three other patents under Section<br />

101. Two patents contained claims that were directed to methods<br />

of “halftoning” images by utilizing pixel-by-pixel comparisons of<br />

an image against a particular mask. In addressing these claims,<br />

the court noted that the “only component that could require a<br />

‘machine’ in the patents is the pixel-by-pixel comparison.” Id. at *35.<br />

However, the court noted that this comparison does not necessarily<br />

require a machine, but “instead it could be done on a sheet of paper<br />

using a pen.” Id. at *37. “The patent claims for the [] patents do<br />

not mandate the use of a machine to achieve their algorithmic and<br />

algebraic ends. Simply because a digital apparatus such as a computer,<br />

calculator, or the like could assist with this comparison does<br />

not render it patent-eligible material. RCT’s argument that a pixel<br />

by its nature is electronic and therefore necessitates a machine is a<br />

post solution argument and the Court rejects it.” Id. After finding<br />

that these claims were not tied to a particular machine, the court<br />

also concluded that the claims did not require the transformation of a<br />

specific article. The claims did not “require the transformation of the<br />

gray scale images into another image … [T]hese two patents merely<br />

recite the comparison as something ‘which is designed to produce …’<br />

dot profiles. The claim does not make this production or transformation<br />

a realized action through the patent process. Instead it recites it<br />

as a potential outcome of the comparison and does not require any<br />

visual depiction or subsequent display.” Id. at *38-39. 7<br />

In H&R Block Tax Services, Inc. v. Jackson-Hewitt Tax Service,<br />

Inc., Case No. 6:08-cv-00037, Docket No. 107 (E.D. Tex. Nov. 10,<br />

2009), the magistrate judge recently recommended that the court<br />

partially grant a motion for summary judgment of invalidity based on<br />

arguments that the patent claims at issue failed Bilski’s “machineor-transformation”<br />

test. Some of the claims at issue involved “computerized<br />

system” claims for providing a loan based on an anticipated<br />

tax refund, as well as a “computer-implemented method” for<br />

providing a loan to a taxpayer based on an anticipated tax refund. In<br />

some claims, the loan was provided on a “spending vehicle,” such as<br />

a prepaid credit card or similar device.<br />

Drawing inferences in the plaintiff’s favor for the purpose of summary<br />

judgment, the magistrate nevertheless found that the “computerized<br />

systems” claims were not patent-eligible under Section 101<br />

and thus invalid. In particular, the magistrate found that the claims<br />

directed to a “computerized system for distributing spending vehicles”<br />

involved assigning rights and financial relationships between<br />

entities, which he found was “simply an abstract intellectual<br />

concept” and, although they were not process claims as in Bilski,<br />

they ran afoul of the Supreme Court’s prohibition against claiming a<br />

fundamental principle. Id. at 10 & n.2. 8 In general, the magistrate<br />

found that, to the extent the computerized system claims recited a<br />

computer, it was “not a particular, special-purpose machine,” and<br />

thus was “an insignificant, extra-solution component of the claimed<br />

system” that failed to impose any meaningful limits on the claim or<br />

render an otherwise patent-ineligible claim eligible. Id. at 11, 12. 9<br />

The remaining claims at issue recited “a method utilizing an ‘electronic<br />

tax preparation system,’” which the plaintiff argued required<br />

the use of a computer. Id. at 13. The magistrate found that the computer<br />

was involved in three of the steps: (1) preparing a tax return;<br />

(2) obtaining tax return data; and (3) executing an agreement related<br />

to a spending vehicle. The magistrate found the computer’s use in<br />

the first two steps insufficient to make the claimed process patenteligible.<br />

On the other hand, the magistrate found that the third step<br />

of executing an agreement was an essential part of the claim (and<br />

( continued on page 14 )


( continued from page 13 )<br />

thus not insignificant extra-solution activity), and imposed meaningful<br />

limits on the claims since it does not preempt all methods<br />

of executing such agreements. Id. at 14. Based on this finding,<br />

the magistrate found the method claims to be sufficiently tied to a<br />

particular machine to pass Bilski’s “machine-or-transformation test”<br />

for patentable subject matter. Id. at 15.<br />

Other Post-Bilski Decisions<br />

While the Federal Circuit and a few district courts have issued opinions<br />

relying upon Bilski, the BPAI has been very active in applying<br />

the machine-or-transformation test. In particular, since Bilski was<br />

decided, the BPAI has issued almost 100 decisions purporting to<br />

apply the Federal Circuit’s test for patent eligibility. Some of the<br />

BPAI’s decisions are simple extensions of Bilski, rejecting claims<br />

that recite methods of organizing human or business activities.<br />

However, numerous BPAI decisions address claims that, prior<br />

to Bilski, were routinely approved as patent-eligible (e.g., claims<br />

reciting a computer-readable medium and/or a system containing<br />

a processor for executing a sequence of steps). A representative<br />

sampling of the BPAI’s decisions reveals that it is not business<br />

as usual at the PTO when it comes to applying the test for patent<br />

eligibility under Section 101.<br />

Methods for Identifying Information or Organizing Activities<br />

Have Been Rejected<br />

In line with the Federal Circuit’s statement that method steps<br />

manipulating legal obligations, legal relationships, business risks,<br />

human activities or other such abstractions cannot meet the patent<br />

eligibility test because such steps are not applied to physical objects<br />

or substances, the BPAI routinely has rejected claims that are not<br />

tied to a particular machine, merely organize human activities or<br />

merely gather information for identification purposes. For instance,<br />

in Ex parte Toth, No. 2008-4543, 2009 Pat. App. LEXIS 13 (BPAI<br />

June 15, 2009), the BPAI rejected claims under Section 101 that<br />

were directed to methods for “providing a one game scratch match<br />

play single elimination tournament for league players.” Id. at *1. The<br />

steps of the method included providing a pool of players, placing<br />

players into divisions and conducting various rounds of competition.<br />

The claims were rejected under Section 101 as they did not “limit<br />

the play to any particular game” and did “not limit the method to<br />

implementation using any particular machine or apparatus.” Id. at<br />

*5-6. The claims were analogized to the rejected claims in Bilski<br />

as the pending claims merely called for the performance of method<br />

steps “that involve transformations or manipulations of relationships.”<br />

Id. at *6.<br />

In a companion case decided the same day, Ex parte Toth, No.<br />

2009-9323, 2009 Pat. App. LEXIS 15 (BPAI June 15, 2009), the<br />

BPAI similarly rejected claims directed to “a one game scratch<br />

match play single elimination tournament for league players.” Id.<br />

at *1. Unlike the prior case, the claims involved in this appeal did<br />

identify a game (“setting a minimum number of games bowled”)<br />

and did recite some apparatus elements (e.g., bowling pins: “establishing<br />

multiple average divisions based on 10-pin or 15-pin average<br />

divisions;” television broadcasting: “each division champion<br />

bowling in separate television telecasts”). Despite these recitations,<br />

the BPAI held that the claims did not satisfy Section 101 as<br />

they were not “tied to a particular machine or apparatus.” Id. at<br />

*6. The BPAI held that the recitation of “pins” was not sufficient,<br />

nor carried throughout the claims so as to limit them to a particular<br />

apparatus, as “the competition could be conducted via a computer<br />

IP® EVIEW<br />

14<br />

in a virtual bowling tournament or in person with an actual bowling<br />

ball and pins.” Id. at *6-7. With regard to the television telecast<br />

reference, the BPAI held that references “in the claim to television<br />

telecasts do not impose any meaningful limits on the claimed<br />

method because the method is directed to tournament play to<br />

determine a champion and thus the display of the actual championship<br />

play on the television is merely ‘insignificant extra-solution<br />

activity.’” Id. at *7.<br />

With regard to methods for identifying information or organizing<br />

activities, the BPAI similarly has rejected the following types of<br />

claims: steps for implementing a best practice idea within an organization<br />

10 , steps for collecting payments from customers having<br />

delinquent accounts 11 , steps for selecting software and hardware<br />

based on business needs 12 , steps for preventing the processing of<br />

suspect trades 13 , steps for identifying relationships between users<br />

of a social networking site 14 , steps for establishing the reliability of<br />

a part based on data analysis 15 , steps for developing a solution to<br />

customer experience requirements 16 , steps for making healthcare<br />

patient credit decisions 17 , and steps for identifying trade secrets of<br />

a business. 18<br />

Recitation of a Computer Not Always Sufficient<br />

Since Bilski was decided, numerous claims reciting a general<br />

purpose computer or processor have been rejected as insufficiently<br />

tied to a particular machine. For instance, in Ex parte Gutta, No.<br />

2008-3000, 2009 Commr. Pat. LEXIS 59 (Jan. 15, 2009), new<br />

grounds for rejection under Section 101 were entered for several<br />

claims directed to a computerized method for recommending<br />

items to a target user. The claims at issue recited a computerized<br />

method “performed by a data processor” for recommending one or<br />

more items based in part on the selection history of a third party.<br />

Id. at *1. The method claims also recited a step of displaying a recommendation<br />

score to a target user. Id. at *2. The opinion noted<br />

that the recitation of these elements fell within the category of<br />

claims that Bilski did not address. 19 Nonetheless, the claims were<br />

rejected for not complying with the machine-or-transformation test.<br />

The inclusion of a “computerized method performed by a data<br />

processor” phrase in the claims was held to be insufficient under<br />

the first prong of the Bilski test in that the phrase added “nothing<br />

more than a general purpose computer that is associated with the<br />

steps of the process in an unspecified manner. Such a field-of-use<br />

limitation is insufficient to render an otherwise ineligible process<br />

claim patent eligible.” Id. at *6. Similarly, the step of “displaying”<br />

was not tied to any particular machine and could “be accomplished<br />

simply by writing the resulting score on a piece of paper.” Id. at<br />

*6-7. Finally, the opinion noted that the claims failed the transformation<br />

prong of the Bilski test because the data being manipulated<br />

did “not represent physical and tangible objects. Rather, the data<br />

represents information about user selection histories, an intangible.”<br />

Id. at *7.<br />

More recently, in Ex parte Myr, App. 2009-005949 (BPAI Sept.<br />

18, 2009), the BPAI rejected method claims directed “a computer<br />

implemented method for appraising real estate.” The BPAI<br />

held that steps of “storing” values constituted data gathering,<br />

“performing nonlinear programming” was a formula-manipulating<br />

step, and that “providing signals” was a post-solution activity. Id.<br />

at 12-14. Since the method did not transform a particular article<br />

into a different state or thing (appraising “does not transform the<br />

land in any physical way”), the BPAI analyzed whether “computerimplemented”<br />

in the preamble of the claim was sufficient to render<br />

( continued on page 15 )


( continued from page 14 )<br />

the claim patent-eligible as “tied to a particular machine.” “Given<br />

that claim 1 recites no other structure in the body of the claim, the<br />

phrase ‘computer-implemented’ in the preamble of claim 1 is a<br />

nominal recitation of structure.” Id. at 17. “To elevate such a token<br />

recitation of a computer to that of a ‘particular’ machine that would<br />

satisfy the machine prong of the Bilski machine-or-transformation<br />

test would be to permit clever drafting of process subject matter<br />

not contemplated by the case law and to exalt form over substance<br />

in determining whether the claimed process passes § 101 muster.”<br />

Id. at 18.<br />

In Ex parte Greene, App. No. 2008-4073 (BPAI April 24, 2009), the<br />

BPAI addressed claims directed to a “computer system for performing<br />

a fast Fourier transform” that included “one or more vector<br />

processors configured as” “a non-final stage calculating means”<br />

and “a final stage calculating means.” Id. at 2-3. While the BPAI<br />

found the claims to be “clearly” distinguishable from the process<br />

claims at issue in Bilski, the BPAI nonetheless held the claims to be<br />

patent-ineligible under Section 101. The BPAI considered the claims<br />

as “apparatus claims that implement a mathematical algorithm (i.e.,<br />

a Fast Fourier Transform).” Id. at 11. In rejecting the claims, the<br />

BPAI emphasized that the output results of the calculation were “not<br />

used for any practical purpose or inventive application.” Id. at 13.<br />

The BPAI also held that the claims were not limited to a particular<br />

type of computer system: “Indeed, Appellant’s Specification<br />

expressly discloses that ‘[t]he method can be embodied in software<br />

that can run on a variety of computers known in the art, including<br />

without limitation, personal computers, workstation computers, and<br />

supercomputers known in the art.’” Id. (emphasis in original). If<br />

these “conventional hardware elements” were removed from the<br />

claim, the BPAI noted that the claims would be nonstatutory as<br />

being directed to an abstract idea and/or a fundamental principal (a<br />

mathematical algorithm). Id. In short, the BPAI held that “merely<br />

adding a nominal recitation of conventional computer hardware in a<br />

claim otherwise directed to a pure mathematical algorithm is merely<br />

an exercise in claim drafting that cannot, by itself, render the claim<br />

statutory.” Id. at 14. 20<br />

In Ex parte Snyder, App. No. 2008-4598 (BPAI May 12, 2009), the<br />

BPAI affirmed the rejection of claims directed to transforming text<br />

documents to XML documents. Certain claims were written as a<br />

“text to XML transformer, comprising: a transformer program …<br />

and a processor for executing,” while other claims were written as<br />

a process for converting text to XML. The BPAI held that recitation<br />

of “a processor” only nominally connected the claimed transformer<br />

to a machine since the processor was only recited for the purpose<br />

of executing the transformer program. Id. at 22. The specification<br />

did not disclose any particular processor, but instead suggested<br />

that “any and every possible processor for performing the function”<br />

could be used. Id. In these circumstances, the BPAI held that the<br />

claimed transformer was not a machine. While the process claims<br />

did not recite a processor or computer, they did recite executing a<br />

program. Nonetheless, the BPAI held that the process claims were<br />

not tied to any particular machine. Id. at 23. In addition, the BPAI<br />

stated that the only “transformation” occurring in the claims was a<br />

transformation from one digital data form to another. Id. “Here, we<br />

do not have a transformation of physical subject matter but merely<br />

an abstract expression that is created from converting data from text<br />

to XML, which does not require any tangible output or result.” Id. at<br />

24 (emphasis in original). The BPAI held that this type of transformation<br />

did not satisfy the transformation prong of the machine-ortransformation<br />

test.<br />

IP® EVIEW<br />

15<br />

Software in a Computer-Readable Medium Not<br />

Always Patentable<br />

In addition to rejecting claims having a token recitation of a processor<br />

or general purpose computer, the BPAI has been active in rejecting<br />

otherwise ineligible process claims packaged as software stored<br />

on a computer-readable medium. For example, in Ex parte Cornea-<br />

Hasegan, 89 U.S.P.Q.2d (BNA) 1557 (BPAI 2009), the claims at issue<br />

concerned a method for predicting results of floating point mathematical<br />

operations and a computer-readable media including program<br />

instructions to perform the method. Although the method claims<br />

recited the use of a processor to perform the steps, the BPAI held<br />

that “the recitation of a processor does not limit the process steps<br />

to any specific machine or apparatus.” Id. at 1560. 21 The BPAI also<br />

held that the method claims did not transform an article or physical<br />

thing. “Rather, the data represents information about an abstract<br />

floating-point number, which is intangible.” Id. After addressing the<br />

method claims, the BPAI affirmed the rejection of claims directed to<br />

computer-readable media: “When broadly construed … the claimed<br />

‘computer-readable media’ limits the scope of the claimed media to<br />

tangible media embodiments such as the disclosed ‘fixed magnetic<br />

disk, [] floppy disk drive, [] optical disk drive, [] magneto-optical<br />

disk drive, [] magnetic tape, or non-volatile memory including flash<br />

memory.’ Even so, analysis of a ‘manufacture’ claim and a ‘process’<br />

claim is the same under Section 101.” Id. at 1561 (citations omitted).<br />

Thus, despite the recitation of tangible media, the BPAI concluded<br />

that the claim “is still directed to determining a result d from a<br />

mathematical algorithm. Additional recitations of computer- readable<br />

media, a hardware prediction unit, steps manipulating other<br />

data (floating-point operands) and determining whether to calculate<br />

d using floating point hardware are still insignificant extra-solution<br />

activities that fail to ‘transform an unpatentable principle into a<br />

patentable process.’ Limiting the claim to computer-readable media<br />

does not add any practical limitation to the scope of the claim.” Id. at<br />

1561 (citations omitted).<br />

Similarly, in Ex parte Mitchell, App. No. 2008-2012 (BPAI Feb. 23,<br />

2009), the BPAI affirmed the rejection of method, computer-readable<br />

medium, and system claims under Section 101. The claims were<br />

directed to “identifying co-evolving regions in the memory of a<br />

target application” so as to prevent computer memory space from<br />

being reclaimed for other uses in the computer. The BPAI rejected<br />

the method claims under the machine-or-transformation test as the<br />

claims were not tied to a particular machine and they did not recite<br />

an article that was transformed to a different state or thing. The<br />

computer-readable medium claim was rejected for the same reason:<br />

“We see no reason why a ‘computer-readable medium’ containing<br />

‘instructions’ for the otherwise ineligible method should be treated<br />

any differently from the non-statutory method recited in” the<br />

method claim. Id. at 8. The “system” claim was likewise rejected:<br />

“Limiting the claim to part of a system comprising a ‘processor’ and<br />

‘memory’ does not add any practical limitation to the scope of the<br />

claim. Similar to a field-of-use limitation in a process claim, the use<br />

of a general ‘processor’ and ‘memory’ is insufficient to render an<br />

otherwise ineligible claim patent eligible.” Id. at 11. 22<br />

In Ex parte Gutta, App. No. 2008-4366 (BPAI Aug. 10, 2009), the<br />

BPAI addressed three types of claims: (1) methods for identifying<br />

one or more mean items for a plurality of items, (2) systems for<br />

identifying one or more mean items including a memory and a<br />

processor configured to compute various values, and (3) an article<br />

of manufacture for identifying one or more mean items comprising<br />

a computer-readable medium having computer-readable program<br />

( continued on page 16 )


( continued from page 15 )<br />

code to perform various steps. The BPAI held that all three types<br />

of claims were not statutory under Section 101. With regard to<br />

the method claims, the BPAI held that they were not tied to any<br />

particular machine and they did not transform an item into a different<br />

state or thing. However, when addressing the system and article of<br />

manufacture claims, the BPAI applied a modified version of the Bilski<br />

test to determine patent eligibility. In particular, the BPAI noted that<br />

a machine or article of manufacture that involves a mathematical<br />

algorithm is not patent-eligible if it fails one of these two tests: “(1)<br />

Is the claim limited to a tangible practical application, in which the<br />

mathematical algorithm is applied, that results in a real-world use<br />

(e.g., ‘not a mere field-of-use label having no significance’)? (2) Is<br />

the claim limited so as to not encompass substantially all practical<br />

applications of the mathematical algorithm either ‘in all fields’ of use<br />

of the algorithm or even in ‘only one field?’” Ex parte Gutta, App.<br />

No. 2008-4366 at 15. 23 Applying these tests, the BPAI held that<br />

the system and computer-readable medium claims were not patenteligible<br />

because they encompassed all practical applications of the<br />

mathematical algorithm and thus claimed “the algorithm itself.” Id.<br />

at 22.<br />

Computer Simulations May Not Pass Muster Under<br />

Section 101<br />

In a recent decision, the BPAI applied Section 101 to reject claims<br />

directed to methods for rendering “a volumetric obscurant” (e.g.,<br />

a simulated cloud) “in a computer generated graphical image” by<br />

executing an algorithm defining a polygon region having pixels,<br />

spreading the pixels, and modulating a density of the pixels “to<br />

create a realistic image of a volumetric obscurant.” In Ex parte<br />

Gardiner, App. No. 2009-001597 (BPAI Oct. 22, 2009), the BPAI<br />

rejected the pending claims as not being tied to a particular machine.<br />

The BPAI noted that “the claimed method is directed to applying<br />

the algorithm to an image and is therefore not tied to a particular<br />

machine.” Id. at 5. The BPAI also held that transforming a computer<br />

image into another image containing a cloud (as would be accomplished<br />

in simulating the visual effect of an airplane flying through<br />

a cloud) does not transform an article into a different state or thing<br />

under the machine-or-transformation test: “neither the polygon nor<br />

the obscurant represents a physical item; rather, the polygon is an<br />

abstraction to define a region of an image. The obscurant is also<br />

an abstraction as it is not based upon a physical item, but rather is<br />

part of a simulation … Thus [] the steps … recited in claim 1 do not<br />

transform any physical object.” Id. at 6. 24<br />

Argument Before the Supreme Court<br />

On November 9, 2009, the Supreme Court heard oral arguments in<br />

the appeal of the Federal Circuit’s en banc Bilski opinion. Although it<br />

was unclear from the oral argument how the Court might rule, it was<br />

clear that the Justices recognized the importance of this case and<br />

the potential far-reaching effects of any decision they may render,<br />

noting in particular the “80 briefs” filed in the case. Bilski v. Kappos,<br />

Case No. 08-964, Official Transcript, 32:1-4 (Sup. Ct. Nov. 9, 2009).<br />

A majority of the Justices appeared to have some level of discomfort<br />

with the claims in Bilski’s patent and, thus, it seems unlikely that the<br />

Court will find Bilski’s patent claims to be patent-eligible. Several<br />

of the Justices noted that the Bilski patent application was directed<br />

to the types of processes for which patents were not sought years<br />

ago—suggesting that these types of claims were not patent-eligible.<br />

Chief Justice Roberts and Justice Kennedy noted that risk hedging<br />

has been common in the insurance industry for years without the<br />

protection of patents. Justice Sotomayor expressed doubts about<br />

IP® EVIEW<br />

16<br />

the benefit of patents like Bilski’s that only require human activities,<br />

without requiring any technology, asking “why not patent a method<br />

of speed dating?” Id. at 7:7-12. The Justices gave other examples of<br />

the types of protection that they thought would be similarly ineligible<br />

for patent protection: buying low and selling high to maximize<br />

wealth, attempting to patent a horse training technique, attempting<br />

to patent a technique of writing a book on how to win friends and<br />

influence people, attempting to patent a method for teaching antitrust<br />

law, and speed-dating.<br />

Bilski’s counsel argued that the claims are valid, not under the<br />

machine-or-transformation test, rather because they involved<br />

physical steps. Upon making that argument, he was interrupted by<br />

the Chief Justice asking:<br />

CHIEF JUSTICE ROBERTS: I’m sorry. Just what are<br />

the physical steps? Initiating a series of transactions<br />

between commodity provider and market participants?<br />

MR. JAKES: That would be one.<br />

CHIEF JUSTICE ROBERTS: You get on the phone and<br />

you call the baker and you get on the phone and you call<br />

the grocer and say: I can set up a deal for both of you?<br />

Id. at 11:19-12:2. Chief Justice Roberts later emphasized this same<br />

point on rebuttal, hinting at his dissatisfaction at a patent claim<br />

covering people conducting a transaction by phone.<br />

With regard to the test for patent eligibility, the Justices seemed<br />

concerned with the outer bounds of the Federal Circuit’s machineor-transformation<br />

test, noting that it leaves “much unresolved,”<br />

such as what the terms “machine” and “transformation” actually<br />

mean and how broad or narrow they are. Id. at 32. In addition, there<br />

was concern about the quality of the machine or the transformation<br />

with respect to the invention being claimed. Chief Justice Roberts<br />

was concerned that “the most tangential and insignificant use of a<br />

machine” might be able to transform something otherwise unpatetentable<br />

into something patentable. Id. at 33:3-7.<br />

It is far from certain how the Justices will articulate the test to<br />

govern patent eligibility under Section 101. One possibility is that<br />

they affirm the Federal Circuit’s machine-or-transformation test as<br />

there appears to be a general consensus that Bilski’s pending claims<br />

should not be patent-eligible. However, there is the possibility that<br />

they may make a narrow ruling. The government attorney noted<br />

explicitly that this case may not be the best vehicle for determining<br />

the bounds of patent-eligible subject matter in subject areas like<br />

software and medical diagnostics. Id. at 36:10-22. Indeed, the<br />

Court has waded into this murky water before, only to express its<br />

displeasure at the state of the law on patent-eligible subject matter<br />

without making any decision. 25<br />

Conclusion<br />

Although uncertainty exists as to what test the Supreme Court will<br />

articulate to judge questions of patent eligibility, it is clear that the<br />

Federal Circuit, district courts, BPAI and PTO have embraced Bilski’s<br />

machine-or-transformation test and are willing to invalidate and/or<br />

reject claims that do not meet the test. To prepare for the possibility<br />

that the Supreme Court will affirm this test for patent eligibility, patentees<br />

and patent applicants should conduct a serious review of their<br />

pending applications and existing United States patent portfolios to<br />

( continued on page 17 )


( continued from page 16 )<br />

make sure that their claims will pass the machine-or-transformation<br />

test. While changes to claims in pending applications can be made<br />

through simple amendments, revising claims through reissue is<br />

not as simple. Moreover, as the average prosecution pendency<br />

of reissue applications is approaching five years, patentees should<br />

review their portfolios during the pendency of the Bilski appeal so<br />

that they are ready to pursue reissue applications, if necessary,<br />

shortly after the Supreme Court renders its decision.<br />

In terms of strategic considerations for litigation, amendments to<br />

pleadings should be made where necessary to assert arguments<br />

that are available under the Bilski line of decisions. Similarly, where<br />

claims of any patents-in-suit appear to fail the Federal Circuit’s<br />

machine-or-transformation step, it may make sense to consider<br />

summary judgment motions based on Bilski and its progeny.<br />

Additionally, licenses and/or settlement agreements that involve<br />

patents that are on shaky ground under Bilski should be reviewed.<br />

As with preparations of reissue applications, it makes sense to begin<br />

reviewing these documents during the pendency of the Bilski appeal<br />

to be ready to approach the other parties once the Supreme Court<br />

renders its decision. �<br />

1 This test, derived from a series of cases, namely In re Freeman, 573 F.2d 1237 (CCPA<br />

1978), In re Walter, 618 F.2d 758 (CCPA 1980), and In re Abele, 684 F.2d 902 (CCPA<br />

1982), involved two steps: (1) determining if the claim recited an algorithm and (2)<br />

determining whether the algorithm was applied in any manner to physical elements<br />

or process steps.<br />

2 The “useful, concrete and tangible result” test arose from several cases, namely<br />

AT&T Corp. v. Excel Commc’ns, Inc., 172 F.3d 1352 (Fed. Cir. 1999), State St. Bank &<br />

Trust Co. v. Signature Fin. Group, 149 F.3d 1368 (Fed. Cir. 1998), and In re Alappat, 33<br />

F.3d 1526 (Fed. Cir. 1994).<br />

3 The applicants in Ferguson proposed that the Federal Circuit consider a new test:<br />

“Does the claimed subject matter require that the product or process has more<br />

than a scintilla of interaction with the real world in a specific way?” In re Ferguson,<br />

558 F.3d at 1364. The Federal Circuit rejected that proposal and reaffirmed the<br />

machine-or-transformation test as the sole test for a process claim under Section<br />

101. Id. Like the applicants in Ferguson, amici filing briefs with the Supreme<br />

Court have proposed various different tests for patent eligibility. See, e.g., Brief<br />

for Bank of America et al. (processes are patent-eligible only when physically<br />

transformative or tied to the nonconventional use of a particular machine); Brief for<br />

Microsoft Corporation et al. (processes are patent-eligible when they describe a<br />

series of steps that use physical means to produce a result or effect in the physical<br />

world); Brief for Dolby Labs. et al. (processes that apply scientific/technological<br />

principles to achieve a result that has practical application are patent-eligible); Brief<br />

of Regulatory Datacorp, Inc. et al. (ordinary, broad meaning of process should<br />

be adopted in view of normal statutory construction principles); Brief of Yahoo!<br />

Inc. (patent eligibility predicated upon whether the claimed process sets forth<br />

a series of clearly defined steps that are stable, predictable, and reproducible);<br />

Brief for Bilski (practical application of a principle in an art or process is the test for<br />

patent eligibility); Brief for IBM (patent eligibility depends upon whether a process<br />

provides a technological contribution without preempting the use of laws of nature,<br />

natural phenomena, mental processes, or abstract ideas); Brief for 20 Law and<br />

Business Professors (applied ideas are eligible for patenting, whereas ideas in the<br />

abstract are not).<br />

4 The Federal Circuit’s decision in Prometheus Labs. likely will be applied to a<br />

matter currently on appeal to the Federal Circuit. In King Pharmaceuticals, Inc.<br />

v. Eon Labs, Inc., 593 F. Supp. 2d 501 (E.D.N.Y. 2009), the district court granted<br />

summary judgment that a dependent claim was invalid under Section 101 because<br />

it only recited the step of informing another person of the effect of administering<br />

a particular drug with or without food. The court held that the “act of informing<br />

another person of the food effect of metaxalone does not transform the<br />

metaxalone into a different state or thing.” King Pharmaceuticals, 593 F. Supp. 2d<br />

at 512-13. However, in light of the Federal Circuit’s determination in Prometheus<br />

Labs. that administering drugs is “always transformative,” it is unlikely that the<br />

court’s decision in King Pharmaceuticals will stand since the independent claim<br />

recites the positive step of “administering to the patient a therapeutically effective<br />

amount of metaxalone”. Id. at 506.<br />

5 A similar conclusion was reached in Ex parte Roberts, App. No. 2009-009323 (BPAI<br />

June 19, 2009), wherein the BPAI rejected a claim directed to a method for creating a<br />

real estate investment instrument adapted for performing tax-deferred exchanges.<br />

IP® EVIEW<br />

17<br />

6 In making this determination, the court did not squarely address the language of<br />

Section 100(b) that a “process” “includes a new use of a known … machine.” It is<br />

not clear that any court has squarely addressed the argument of whether software<br />

operating on a computer or processor constitutes a new use (e.g., enumerated<br />

software routines) of a known machine (e.g., a general purpose computer).<br />

7 In contrast to the two patents that were invalidated, the court confirmed the<br />

patentability of three patents under Section 101. These patents also had claims<br />

directed to methods of “halftoning.” However, unlike the other two patents, these<br />

patents had limitations requiring the production of a “halftoned image.” While the<br />

court concluded that the claims in the three patents did not meet the first prong<br />

of the Bilski test (tied to a particular machine), the court held that they did satisfy<br />

the second prong (transformation). In particular, the halftoned images “are the<br />

manifestation of a particular transformation. The patent dictates a transformation of<br />

specific data, and is further limited to a visual depiction which represents specific<br />

objects.” Research Corp. Technologies, Inc. v. Microsoft Corp., 2009 U.S. Dist. LEXIS<br />

71883 at *45.<br />

8 Specifically, the magistrate cited Funk Bros. Seed Co. v. Kalo Co., 333 U.S. 127<br />

(1948), as holding invalid a product claim for preempting a fundamental principle,<br />

and Gottschalk v. Benson, 409 U.S. 63 (1972), as holding invalid a process claim for<br />

preempting a fundamental principle.<br />

9 The magistrate analogized the “extra-solution component” of the computerized<br />

system claims to the “extra-solution step” that the Federal Circuit held in Bilski would<br />

be insufficient to render otherwise unpatentable process claims patent-eligible.<br />

10 Ex parte Sandoval, App. No. 2009-000175 (BPAI Sept. 25, 2009).<br />

11 Ex parte Haworth, App. 2009-000350 (BPAI July 30, 2009).<br />

12 Ex parte Hemmat, App. No. 2009-003911 (BPAI Oct. 13, 2009).<br />

13 Ex parte Delta, App. No. 2009-000982 (BPAI May 26, 2009).<br />

14 Ex parte Dom, App. No. 2008-002470 (BPAI May 29, 2009).<br />

15 Ex parte Babu, App. No. 2008-4851 (BPAI May 29, 2009).<br />

16 Ex parte Farnes, App. No. 2009-002770 (BPAI June 2, 2009).<br />

17 Ex parte Johnson, App. No. 2009-000714 (BPAI June 8, 2009).<br />

18 Ex parte Halligan, 89 U.S.P.Q.2d (BNA) 1355 (BPAI 2008).<br />

19 In rendering its decision in Bilski, the Federal Circuit noted that it would “leave to<br />

future cases the elaboration of the precise contours of machine implementation, as<br />

well as the answers to particular questions, such as whether or when recitation of<br />

a computer suffices to tie a process claim to a particular machine.” Bilski, 545 F.3d<br />

at 962.<br />

20 See also Ex parte Holtz, App. No. 2008-004440 (BPAI Aug. 24, 2009); Ex parte Goud,<br />

App. No. 2008-003121 (BPAI July 20, 2009); Ex parte Dang, App. No. 2009-000984<br />

(BPAI June 29, 2009); Ex parte Caputo, App. No. 2008-004868 (BPAI June 18, 2009)<br />

(an “unspecified ‘processing’ or ‘computing’ device performing the claims algorithm<br />

is not sufficient … to tie the claimed process to a ‘particular’ machine or apparatus”);<br />

Ex parte Avinash, App. No. 2009-1542 at 22 (BPAI June 2, 2009) (“a general purpose<br />

computing system does not tie claim 10 to a special purpose or particular machine”);<br />

Ex parte Nawathe, App. No. 2007-3360 (BPAI Feb. 9, 2009).<br />

21 With regard to the “processor” limitation, the BPAI also commented as follows:<br />

“The recitation of a ‘processor’ performing various functions is nothing more than a<br />

general purpose computer that has been programmed in an unspecified manner to<br />

implement the functional steps recited in the claims. The recitation of a processor in<br />

combination with purely functional recitations of method steps, where the functions<br />

are implemented using an unspecified algorithm, is insufficient to transform<br />

otherwise unpatentable method steps into a patent eligible process.” Ex parte<br />

Cornea-Hasegan, 89 U.S.P.Q.2d (BNA) at 1560-61.<br />

22 See also Ex parte Busche, App. No. 2008-004750 (BPAI May 28, 2009) (rejecting<br />

claims directed to a “computer program product in a computer-readable medium<br />

comprising instructions for enabling a data processing machine to select data<br />

sets”); Ex parte Mau, App. No. 2009-0065 (BPAI May 1, 2009) (“merely reciting<br />

data or instructions on a stored computer-readable medium does not make a<br />

claim patentable”).<br />

23 See also Ex parte Market, App. No. 2009-001843 at 6 (BPAI Oct. 23, 2009) (same); Ex<br />

parte Forman, App. No. 2008-005348 at 16 (BPAI Aug. 17, 2009) (same).<br />

24 See also Ex parte Petculescu, App. No. 2008-002859 (BPAI June 4, 2009) (purported<br />

transformation of data about an intangible, abstract dimensional model is not patenteligible).<br />

25 See LabCorp. v. Metabolite Labs., Inc., 548 U.S. 124 (2006) (writ of certiorari on case<br />

involving diagnostic test dismissed as improvidently granted on a 5-3 vote; Justices<br />

Breyer, Stevens and Souter dissenting that the subject patent claim was directed to a<br />

natural process and unpatentable).


<strong>Skadden</strong> Contacts<br />

New York Office<br />

4 Times Square | New York, NY 10036<br />

Daniel A. DeVito | Partner<br />

212.735.3210 | Daniel.DeVito@skadden.com<br />

Anthony J. Dreyer | Partner<br />

212.735.3097 | Anthony.Dreyer@skadden.com<br />

Jose A. Esteves | Partner<br />

212.735.2948 | Jose.Esteves@skadden.com<br />

Edward V. Filardi | Partner<br />

212.735.3060 | Edward.Filardi@skadden.com<br />

Bruce J. Goldner | Partner<br />

212.735.2972 | Bruce.Goldner@skadden.com<br />

Stuart D. Levi | Partner<br />

212.735.2750 | Stuart.Levi@skadden.com<br />

Douglas R. Nemec | Partner<br />

212.735.2419 | Douglas.Nemec@skadden.com<br />

Kenneth A. Plevan | Partner<br />

212.735.3410 | Kenneth.Plevan@skadden.com<br />

Rita Rodin Johnston | Partner<br />

212.735.3774 | Rita.Rodin@skadden.com<br />

David W. Sussman | Of Counsel<br />

212.735.2686 | David.Sussman@skadden.com<br />

Jessica N. Cohen | Counsel<br />

212.735.2793 | Jessica.Cohen@skadden.com<br />

Mary E. Rasenberger | Counsel<br />

212.735.3565 | Mary.Rasenberger@skadden.com<br />

P. Anthony Sammi | Counsel<br />

212.735.2307 | Anthony.Sammi@skadden.com<br />

IP® EVIEW<br />

18<br />

James S. Talbot | Counsel<br />

212.735.4133 | James.Talbot@skadden.com<br />

Elaine D. Ziff | Counsel<br />

212.735.2656 | Elaine.Ziff@skadden.com<br />

Matthew B. Zisk | Counsel<br />

212.735.3056 | Matthew.Zisk@skadden.com<br />

Palo Alto Office<br />

525 University Ave. | Suite 1100 | Palo Alto, CA 94301<br />

Chuck Ebertin | Partner<br />

650.470.4550 | Chuck.Ebertin@skadden.com<br />

David W. Hansen | Partner<br />

650.470.4560 | David.Hansen@skadden.com<br />

Bernard Shek | Counsel<br />

650.470.4513 | Bernard.Shek@skadden.com<br />

Washington, D.C. Office<br />

1440 New York Avenue, N.W. | Washington, D.C. 20005<br />

Cliff Sloan | Partner<br />

202.371.7040 | Cliff.Sloan@skadden.com<br />

Boston Office<br />

One Beacon Street | Boston, MA 02108<br />

Scott Brown | Counsel<br />

617.573.4874 | Scott.Brown@skadden.com<br />

Justin J. Daniels | Counsel<br />

617.573.4826 | Justin.Daniels@skadden.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!